Introduction
============

Tongue squamous cell carcinoma (TSCC) is the most prevalent type of oral and maxillofacial tumor, with an estimated 14,320 new cases and 2,190 deaths in the US in 2015.[@b1-dddt-9-5511] The most important etiological factors are tobacco, excessive consumption of alcohol, and betel quid usage, which act separately or synergistically.[@b2-dddt-9-5511] It has been reported that TSCC is more commonly found in males, with a percentage of 72.0% of all TSCC cases, compared with a percentage of 28.0% in females.[@b1-dddt-9-5511] Of note, the incidence of TSCC in young white women is significantly increasing, according to the Surveillance, Epidemiology, and End Results program data from 1973 to 2010 in the US.[@b3-dddt-9-5511] Because of the mobility and masticatory function of the tongue, TSCC is inclined to spread locally, involving perioral structures, and metastasize to local regional lymph nodes. For this reason, TSCC always demonstrates a much more aggressive behavior than other kinds of oral and maxillofacial tumors.[@b4-dddt-9-5511] Although there has been advancement in the sequential therapies, including radiation, surgery, and chemotherapy, the patients still suffer from serious relapse and the 5-year survival rate shows no inspiring progress.[@b5-dddt-9-5511] It requires the development of novel therapeutics with improved therapeutic effect and reduced side effect for TSCC treatment.

It has been revealed that acquisition of epithelial to mesenchymal transition (EMT) and induction of cancer stem cell (CSC)-like properties are closely involved in the initiation, development, progression, metastasis, and relapse of solid tumors.[@b6-dddt-9-5511],[@b7-dddt-9-5511] Normal epithelial cells show apical--basal polarity maintained by apical tight junctions and basolateral adherens junctions. The loss of epithelial property and acquisition of mesenchymal features enables cancer cells to metastasize easily and quickly. The reverse process of mesenchymal to epithelial transition (MET) can also occur. Cancer progression is affected by the balance between EMT and MET.[@b8-dddt-9-5511],[@b9-dddt-9-5511] Thus, interfering with the EMT process may help regress cancer metastasis. On the other hand, the proliferation of tumors is driven by a bulk of dedicated stem cells, the CSCs. CSCs, also known as cancer-initiating cells, are involved in cancer cell renewal and differentiation.[@b10-dddt-9-5511] CSCs can display EMT characteristics such as loss of adhesion protein E-cadherin.[@b11-dddt-9-5511] It is reported that CSCs play an important role in chemotherapy resistance due to the self-renewal ability. Multiple oncogenes are involved in the maintenance of stemness and tumorigenicity of CSCs, such as Octamer-4 (Oct-4), Bmi-1, Nanog, and sex-determing region Y-box 2 (Sox-2).[@b12-dddt-9-5511]--[@b15-dddt-9-5511] Hence, targeting the CSCs shows great therapeutic potential in cancer therapy.[@b16-dddt-9-5511]

Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone; PLB) is isolated from the root of *Plumbago zeylanica* L, *Juglans regia*, *Juglans cinerea*, and *Juglans nigra*, with a variety of pharmacological activities including anti-inflammatory, antiatherosclerotic, antibacterial, antifungal, and anticancer activities in in vitro and in vivo models.[@b17-dddt-9-5511] Notably, PLB shows a potent ability in killing cancer cells with minimal side effects.[@b18-dddt-9-5511] Previous studies from our and other groups have shown that PLB regulates various cellular processes such as cell cycle, apoptosis, autophagy, and cellular redox status.[@b19-dddt-9-5511]--[@b21-dddt-9-5511] PLB also induces cancer cell apoptosis and autophagy by inhibition of nuclear factor kappa B (NF-κB) activation and phosphatidylinositide 3-kinase (PI3K)/protein kinase B (Akt)/mTOR signaling pathway.[@b21-dddt-9-5511]--[@b25-dddt-9-5511] Besides, PLB can efficiently facilitate reactive oxygen species (ROS) generation, which also contributes to the cancer cell killing effect.[@b26-dddt-9-5511]--[@b28-dddt-9-5511] However, the full spectrum of the molecular targets and therapeutic effects of PLB in TSCC are not clear.

Accumulating evidence shows that stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomic approach has the capability of revealing the potential targets of a given compound or drug.[@b29-dddt-9-5511],[@b30-dddt-9-5511] In this study, we aimed at elucidating the possible mechanisms for PLB's anticancer effect in the treatment of TSCC using a SILAC-based quantitative proteomic approach to take a panoramic view of PLB in a TSCC cell line (SCC25). The corresponding verifications were also performed. In addition, we also carried out separate experiments to investigate the relationship between PLB-induced ROS generation and PLB-mediated cell cycle arrest, apoptosis induction, EMT inhibition, and stemness attenuation.

Materials and methods
=====================

Chemicals and reagents
----------------------

Dulbecco's Modified Eagle's Medium (DMEM) and Ham's F12 medium were obtained from Corning Cellgro Inc. (Herndon, VA, USA). Fetal bovine serum (FBS), PLB, dimethyl sulfoxide (DMSO), hydrocortisone, *N*-acetyl-[l]{.smallcaps}-cysteine (NAC, a ROS scavenger), [l]{.smallcaps}-glutathione (GSH, a ROS scavenger), ammonium persulfate, [d]{.smallcaps}-glucose, propidium iodide (PI), ribonuclease, protease and phosphatase inhibitor cocktails, radioimmunoprecipitation assay buffer (RIPA), bovine serum albumin (BSA), Tris base, sodium dodecyl sulfate (SDS), ethylenediaminetetraacetic acid, Dulbecco's phosphate-buffered saline (PBS), dithiothreitol (DTT), ^13^C~6~-[l]{.smallcaps}-lysine, [l]{.smallcaps}-lysine, ^13^C~6~ ^15^N~4~-[l]{.smallcaps}-arginine, and [l]{.smallcaps}-arginine were purchased from Sigma-Aldrich (St Louis, MO, USA). FASP™ protein digestion kit was bought from Protein Discovery Inc. (Knoxville, TN, USA). The Annexin V:PE apoptosis detection kit was purchased from BD Pharmingen Biosciences (San Jose, CA, USA). Ionic Detergent Compatibility Reagent (IDCR) kit, nuclear and cytoplasmic extraction kit, Pierce bicinchoninic acid (BCA) protein assay kit, skimmed milk, and Western blotting substrate were bought from Thermo Fisher Scientific (Waltham, MA, USA). The polyvinylidene difluoride (PVDF) membrane was purchased from Bio-Rad (Hercules, CA, USA). Primary antibodies against human CDK1/cdc2, Cyclin B1, cdc25, Fas (TNFRSF6)-associated via death domain (FADD), TNF1 receptor-associated death domain (TRADD), TRAIL-R2 (DR5), cleaved caspase-3 (CC3), E-cadherin, N-cadherin, Snail, Slug, zinc finger E-box-binding homeobox 1 (TCF8/ZEB1), vimentin, β-Catenin, zona occludens protein 1 (ZO-1), claudin-1, Oct-4, Bmi-1, Nanog, Sox-2, and glutathione *S*-transferase (GST) were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA). Primary antibodies against nuclear factor erythroid 2-related factor 2 (Nrf2), NAD(P)H quinone oxidoreductase 1 (NQO1), and heat shock protein 90 (HSP90) were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). The antibodies against human β-actin and Histone H3 were obtained from Santa Cruz Biotechnology Inc.

Cell line and cell culture
--------------------------

The TSCC cell line SCC25 was obtained from the American Type Culture Collection (Manassas, VA, USA) and cultured in a 1:1 mixture of DMEM and Ham's F12 medium containing 1.2 g/L sodium bicarbonate, 2.5 mM [l]{.smallcaps}-glutamine, 15 mM HEPES, and 0.5 mM sodium pyruvate and was supplemented with 400 ng/mL hydrocortisone and 10% heat-inactivated FBS. The cells were maintained at 37°C in a 5% CO~2~/95% air humidified incubator. PLB was dissolved in DMSO with a stock concentration of 100 mM and was freshly diluted to the desired concentrations with the culture medium. The final concentration of DMSO was at 0.05% (v/v, volume per volume). The control cells received only the vehicle. No ethics approval was required for the use of this cell line this paper.

SILAC quantitative proteomics
-----------------------------

Quantitative proteomic experiments were performed using SILAC as described previously.[@b31-dddt-9-5511]--[@b33-dddt-9-5511] Briefly, SCC25 cells were cultured in the medium with or without stable isotope-labeled amino acids (^13^C~6~ [l]{.smallcaps}-lysine and ^13^C~6~ ^15^N~4~ [l]{.smallcaps}-arginine). SCC25 cells were passaged for five times by changing medium or splitting cells. Then, cells with stable isotope-labeled amino acids were treated with 5 μM PLB for 24 hours. Following that, the cell samples were harvested and lysed with hot lysis buffer (100 mM Tris base, 4% SDS, and 100 mM DTT). The proteins were denatured at 95°C for 5 minutes and sonicated at 20% amplitude (AMPL) for 3 seconds with 6 pulses. Later, the samples were centrifuged at 15,000× *g* for 20 minutes and the supernatant was collected in clean tubes. The protein concentration was determined using the IDCR kits. Then, equal amounts of heavy and light protein sample were combined to reach a total volume of 30--60 μL containing 300--600 μg proteins. The combined protein sample was digested using FASP™ protein digestion kit. After proteins were digested, the resultant sample was acidified to pH of 3 and desalted using a C~18~ solid-phase extraction column. The samples were then concentrated using vacuum concentrator at 45°C for 120 minutes and the peptide mixtures (5 μL) were subject to the hybrid linear ion trap-Orbitrap (LTQ Orbitrap XL, Thermo Scientific Inc.). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed using a 10 cm long 75 μm (inner diameter) reversed-phase column packed with 5 μm diameter C~18~ material with 300 Å pore size (New Objective, Woburn, MA, USA), with a gradient mobile phase of 2%--40% acetonitrile in 0.1% formic acid at 200 μL/minute for 125 minutes. The Orbitrap full MS scanning was performed at a mass (*m/z*) resolving power of 60,000, with positive polarity in profile mode (M+H^+^). Peptide SILAC ratio was calculated using MaxQuant version 1.2.0.13. The SILAC ratio was determined by averaging all peptide SILAC ratios from peptides identified of the same protein. The protein IDs were identified using Scaffold 4.3.2 from Proteome Software Inc. (Portland, OR, USA) and the pathway was analyzed using Ingenuity Pathway Analysis (IPA) from QIAGEN (Redwood City, CA, USA).

Cell cycle distribution analysis
--------------------------------

The effect of PLB on cell cycle distribution of SCC25 cells was determined by flow cytometry using PI as the DNA stain as described previously.[@b20-dddt-9-5511] Briefly, SCC25 cells were treated with PLB at concentrations of 0.1, 1, and 5 μM for 24 hours. In separate experiments, SCC25 cells were treated with 5 μM PLB for 6, 24, and 48 hours. In addition, the effect of ROS scavengers (GSH and NAC)[@b34-dddt-9-5511] on PLB-induced G~2~/M arrest was also examined. Cells were trypsinized and resuspended in 1 mL serum-free medium. Subsequently, the cells were fixed with 3 mL 70% ethanol at −20°C overnight. The cells were stained using 50 μg/mL PI. A total number of 1×10^4^ cells was subject to cell cycle analysis using a flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). Finally, the raw data were analyzed by ModFitLT software (version 3.2.1) (Verity Software House, Topsham, MA, USA).

Quantification of cellular apoptosis
------------------------------------

We used Annexin V:PE apoptosis detection kit to measure apoptotic cells after the cells were treated with 0.1, 1, and 5 μM PLB for 24 hours. In separate experiments, SCC25 cells were treated with 5 μM PLB for 6, 24, and 48 hours. In addition, the effect of GSH and NAC on PLB-induced apoptosis was also examined. Briefly, cells were trypsinized and washed twice with cold PBS, and then resuspended in 1× binding buffer with 5 μL of PE Annexin V and 5 μL of 7-amino-actinomycin D at a concentration of 1×10^5^/mL cells in a total volume of 100 μL. The cells were gently mixed and incubated in the dark for 15 minutes at room temperature. Following that, a quota of 1× binding buffer (400 μL) was added to each test tube and the number of apoptotic cells was quantified by flow cytometry (BD LSR II Analyzer) within 1 hour.

Western blotting assay
----------------------

The levels of various cellular proteins were determined using Western blotting assays. The SCC25 cells were incubated with PLB at 0.1, 1, and 5 μM for 24 hours. In separate experiments, SCC25 cells were treated with 5 μM PLB for 6, 24, and 48 hours. After PLB treatment, cells were washed twice with precold PBS and lysed with the RIPA buffer containing the protease inhibitor and phosphatase inhibitor cocktails. In addition, we extracted the nuclear proteins according to the instruction given in the nuclear and cytoplasmic extraction kit. Protein concentrations were measured using the Pierce BCA protein assay kit. Equal amounts of protein samples at 20 μg were electrophoresed on 7%−12% sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS-PAGE) minigel after thermal denaturation for 5 minutes at 95°C. Proteins were transferred onto immobilon PVDF membrane at 80 V for 3 hours at 4°C. Subsequently, membranes were blocked with 5% BSA and probed with indicated primary antibody overnight at 4°C and then blotted with respective secondary antibody. Visualization was performed using the Bio-Rad system. Cytosolic protein level was normalized to the matching densitometric value of β-actin, and nuclear protein level was normalized to the matching densitometric value of Histone H3.

Statistical analysis
--------------------

Data are presented as the mean ± standard deviation (SD). Multiple comparisons were evaluated by one-way analysis of variance (ANOVA), followed by Tukey's multiple comparison. A value of *P*\<0.05 was considered statistically significant. All the assays were performed in triplicate.

Results
=======

Summary of proteomic response to PLB treatment in SCC25 cells
-------------------------------------------------------------

We first performed SILAC-based proteomics to evaluate the potential molecular targets of PLB in SCC25 cells. PLB increased the expression level of 143 protein molecules, but decreased the expression level of 255 protein molecules in SCC25 cells ([Tables 1](#t1-dddt-9-5511){ref-type="table"} and [2](#t2-dddt-9-5511){ref-type="table"}). Subsequently, these proteins were subject to IPA. The results showed that 101 signaling pathways were potentially regulated by PLB in SCC25 cells ([Table 3](#t3-dddt-9-5511){ref-type="table"} and [Figure 1](#f1-dddt-9-5511){ref-type="fig"}). The top ten targeted signaling pathways were EIF2 signaling pathway, regulation of eIF4 and p70S6K signaling, remodeling of epithelial adherens junctions pathway, mTOR signaling pathway, protein ubiquitination pathway, Nrf2-mediated oxidative stress response signaling pathway, epithelial adherens junction signaling pathway, caveolar-mediated endocytosis signaling pathway, RhoA signaling pathway, and oxidative phosphorylation pathway ([Table 3](#t3-dddt-9-5511){ref-type="table"}). Notably, a number of molecules were involved in cell survival, cell proliferation, redox homeostasis, cell metabolism, cell migration, and cell death, such as p53, CDK1/cdc2, FADD, Nrf2, MAPK, mTOR, p70S6K, E-cadherin, and vimentin.

PLB regulates cell cycle regulators of SCC25 cells
--------------------------------------------------

The cell cycle arresting effect of PLB is considered as a critical contributor to its anticancer activities. We treated SCC25 cells with 5 μM PLB for 24 hours, and then, cell samples were subject to quantitative proteomic analysis. The results showed that PLB regulated cell cycle at G~2~/M DNA damage checkpoint in SCC25 cells with the involvement of multiple functional proteins ([Table 3](#t3-dddt-9-5511){ref-type="table"}). These included YWHAQ, PRKDC, YWHAG, YWHAE, YWHAH, YWHAB, YWHAZ, SFN, SKP1, and CDK1 at G~2~/M checkpoint ([Figure 2](#f2-dddt-9-5511){ref-type="fig"}).

PLB regulates apoptosis in SCC25 cells
======================================

Apoptosis is the type I programmed cell death pathway and has been considered as a promising target for the treatment of cancer either via intrinsic (mitochondrial-mediated) or extrinsic (death receptor-mediated) apoptosis pathways. As listed in [Table 3](#t3-dddt-9-5511){ref-type="table"}, PLB regulated apoptotic signaling pathway and death receptor signaling pathway involving a number of functional proteins. These included ACIN1, CAPNS1, MAPK1, RRAS, LMNA, CAPN2, SPTAN1, CYCS, CDK1, PARP1, AIFM1, FADD, and ACTB. Moreover, the IPA results showed that mTOR signaling pathway played a central role in the regulation of cell metabolism, growth, proliferation, and survival through the integration of both intracellular and extracellular signals ([Table 3](#t3-dddt-9-5511){ref-type="table"}). We subsequently investigated extrinsic apoptosis mediated by FADD in SCC25 cells with the treatment of PLB.

PLB regulates EMT pathways in SCC25 cells
-----------------------------------------

EMT has a close association with cell migration, invasion, and stemness. Suppressing the progress of EMT is thought to be clinically helpful for cancer therapy. We analyzed the effect of PLB on EMT-related proteins and signaling pathways using SILAC-based proteomic approach. The proteomic data showed that PLB regulated epithelial adherens junction signaling pathway in SCC25 cells involving a number of functional proteins, including ACTA1, ACTG1, ACTN1, ACTN4, ACTR3, ARPC1B, CTNNA1, CTNND1, DNM1L, EGFR, IQGAP1, JUP, MYH9, RAB7A, RHO1, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B, VAL, VCL, and ZYX.

PLB regulates redox homeostasis involving Nrf2-mediated signaling pathways in SCC25 cells
-----------------------------------------------------------------------------------------

Induction of ROS generation plays a critical role in the cytokine production, contributing to the cancer cell killing effect of PLB. However, the regulatory effect of PLB on ROS generation-related molecules and signaling pathways has not been fully understood. In this study, we observed that PLB regulated several critical signaling pathways related to ROS generation and redox homeostasis in SCC25 cells. Our quantitative proteomic study showed that PLB treatment regulated Nrf2-mediated oxidative stress response and oxidative phosphorylation in SCC25 cells ([Table 2](#t2-dddt-9-5511){ref-type="table"}). A number of functional proteins were found to be involved in these pathways, including ACTA1, ACTG1, CBR, DNAJA2, GSTP1, NQO1, HSP90AA1, PPIB, SOD1, STIP1, and VCP ([Table 2](#t2-dddt-9-5511){ref-type="table"}). Of note, Nrf2-mediated signaling pathways have critical roles in the maintenance of intracellular redox homeostasis in response to various stimuli via regulating antioxidant responsive elements. The quantitative proteomic data suggest that modulation of the expression of functional proteins involved in Nrf2-mediated signaling pathways may contribute to the anticancer effect of PLB in the treatment of TSCC. The results showed that PLB can efficiently induce ROS generation and that this can be abolished by NAC and GSH. Hence, we subsequently studied the relationship of ROS-generation-inducing effect of PLB with other cellular biological functions, including cell cycle arrest, cell apoptosis, and EMT.

Verification of molecular targets of PLB in SCC25 cells by Western blotting assay
---------------------------------------------------------------------------------

Our aforementioned quantitative proteomic studies have predicted and shown that PLB can modulate a number of signaling pathways and functional proteins related to cell proliferation, cell migration, cell death, and cell survival. On the basis of our previous experimental and present proteomic data in SCC25 cells, we further examined the effect of PLB with a focus on cell cycle, apoptosis, EMT, and redox homeostasis and its related signaling pathways to delineate the underlying mechanisms.

PLB induces G~2~/M arrest in SCC25 cells via downregulation of cyclin B1, CDK1/cdc2, and cdc25
----------------------------------------------------------------------------------------------

First, we examined the effect of PLB on cell cycle distribution of SCC25 cells using a flow cytometer. PLB markedly induced a G~2~/M phase arrest (*P*\<0.05, 0.01, or 0.001; [Figure 3](#f3-dddt-9-5511){ref-type="fig"}). Compared with the control cells (2.4%), the percentage of SCC25 cells in G~2~/M phase was increased in a concentration-dependent manner after PLB treatment ([Figure 3A and B](#f3-dddt-9-5511){ref-type="fig"}). The percentage of cells in G~2~/M phase was 5.8%, 9.1%, and 13.1% when treated with PLB at 0.1, 1, and 5 μM, respectively. On the other hand, PLB significantly decreased the percentage of SCC25 cells in G~1~ phase when treated with 5 μM in comparison to the control cells (*P*\<0.001; [Figure 3B](#f3-dddt-9-5511){ref-type="fig"}). In a separate experiment, the effect of 5 μM PLB on cell cycle distribution was examined in SCC25 cells over 48 hours ([Figure 3C and D](#f3-dddt-9-5511){ref-type="fig"}). Compared to the control cells, the percentage of SCC25 cells in the G~2~/M phase was increased from 2.7% at basal level to 8.1%, 9.4%, and 11.1% after 6-, 24-, and 48-hour treatment with 5 μM PLB, respectively (*P*\<0.001; [Figure 3D](#f3-dddt-9-5511){ref-type="fig"}), whereas 5 μM PLB treatment decreased the percentage of SCC25 cells in G~1~ phase from 48.8% at basal level to 41.3% after 48 hours of treatment (*P*\<0.05; [Figure 3D](#f3-dddt-9-5511){ref-type="fig"}).

To explore the mechanisms for PLB-induced cell cycle arrest in SCC25 cells, the expression level of key regulators responsible for G~2~/M checkpoint was examined using Western blotting assay. CDK1/cdc2, cyclin B1, and cdc25 are important regulators for G~2~ to M phase transition and thus their expression level was determined in SCC25 cells. The expression level of cdc2 was marked suppressed in SCC25 cells after treatment with PLB at concentrations of 0.1, 1, and 5 μM for 24 hours (*P*\<0.001; [Figure 4A and C](#f4-dddt-9-5511){ref-type="fig"}). Compared with the control cells, the expression level of cyclin B1 was decreased by 18.3%, 46.0%, and 62.3% when SCC25 cells were treated with 0.1, 1, and 5 μM PLB for 24 hours, respectively (*P*\<0.01 or 0.001; [Figure 4A and C](#f4-dddt-9-5511){ref-type="fig"}). There was a 10.7%, 14.0%, and 35.3% reduction in the expression level of cdc25 in SCC25 cells when treated with PLB at 0.1, 1, and 5 μM for 24 hours, respectively (*P*\<0.05, 0.01, or 0.001; [Figure 4A and C](#f4-dddt-9-5511){ref-type="fig"}). Next, we conducted separate experiment over 48 hours. In comparison to the control cells, the expression level of cdc2 was decreased by 18.3% and 19.0% when SCC25 cells were treated with 5 μM PLB for 24 and 48 hours, respectively (*P*\<0.001; [Figure 4B and D](#f4-dddt-9-5511){ref-type="fig"}); there was a 34.3% and 49.3% reduction in the expression level of cyclin B1 when SCC25 cells were incubated with 5 μM PLB for 24 and 28 hours, respectively (*P*\<0.001; [Figure 4B and D](#f4-dddt-9-5511){ref-type="fig"}); and the expression level of cdc25 was also markedly suppressed (*P*\<0.01 or 0.001; [Figure 4B and D](#f4-dddt-9-5511){ref-type="fig"}). These results demonstrate that PLB downregulates cyclin B1, CDK1/cdc2, and cdc25 in SCC25 cells. Importantly, these results have confirmed the regulatory effect of PLB on cell proliferation-related signaling pathways, which was predicted by our proteomic studies.

PLB induces apoptosis via FADD-mediated extrinsic signaling pathway
-------------------------------------------------------------------

Apoptosis is a typical type of programmed cell death that plays an important role in PLB-induced cancer cell death. Previously, we observed that PLB significantly induced intrinsic apoptosis in SCC25 cells in a concentration- and time-dependent manner.[@b20-dddt-9-5511] On the basis of the results hinted at by the proteomic results ([Figure 5](#f5-dddt-9-5511){ref-type="fig"}), we further tested the apoptosis inducing effect of PLB with a focus on FADD-mediated signaling pathway. First, we employed flow cytometry to analyze the apoptosis-inducing effect of PLB in SCC25 cells. Subsequently, the modulation effect of PLB on the expression of FADD, TRADD, DR5, and cleaved caspase 3 in SCC25 cells was measured with a consideration to fully understand the apoptosis-inducing effect of PLB via FADD-mediated extrinsic signaling pathway. Cells were treated with PLB at concentrations of 0.1, 1, and 5 μM for 24 hours. The apoptosis level was increased from 3.0% to 6.1%, 8.2%, and 20.3% when SCC25 cells were treated with 0.1, 1, and 5 μM for 24 hours, respectively (*P*\<0.05, 0.01, or 0.001; [Figure 6A and B](#f6-dddt-9-5511){ref-type="fig"}). Next, we conducted the time course experiment, and the results showed that the apoptosis level was increased from 3.5% at basal level to 11.4%, 21.2%, and 35.7% when SCC25 cells were treated with 5 μM PLB for 6, 24, and 48 hours, respectively (*P*\<0.001; [Figure 6C and D](#f6-dddt-9-5511){ref-type="fig"}). Furthermore, There was a 1.3- and 1.6-fold increase in the expression level of FADD after SCC25 cells were treated with 1 and 5 μM PLB for 24 hours, respectively (*P*\<0.01 or 0.001; [Figure 7A and C](#f7-dddt-9-5511){ref-type="fig"}). The expression level of TRADD and DR5 was also increased when cells were treated with PLB (*P*\<0.01 or 0.001; [Figure 7A and C](#f7-dddt-9-5511){ref-type="fig"}). The cleavage of caspase 3 is the determinant process in both intrinsic and extrinsic apoptosis. We found that PLB markedly increased the level of cleaved caspase 3 to 1.2- and 1.3-fold when SCC25 cells were treated with 1 and 5 μM for 24 hours, respectively (*P*\<0.01 or 0.001; [Figure 7A and C](#f7-dddt-9-5511){ref-type="fig"}). In a separate experiment, we examined the apoptosis-inducing effect of PLB over 48 hours. The expression level of FADD was increased 1.5-, 1.5-, and 1.6-fold when SCC25 cells were treated with 5 μM for 6, 24, and 48 hours, respectively (*P*\<0.001; [Figure 7B and D](#f7-dddt-9-5511){ref-type="fig"}). The expression level of DR5 was also markedly increased in comparison with the control cells (*P*\<0.05 or 0.001; [Figure 7B and D](#f7-dddt-9-5511){ref-type="fig"}). Meanwhile, there was a 1.1-, 1.3-, and 1--2 fold rise in the expression level of cleaved caspase 3, when SCC25 cells were treated with 5 μM PLB for 6, 24, and 48 hours, respectively (*P*\<0.01 or 0.001; [Figure 7B and D](#f7-dddt-9-5511){ref-type="fig"}). The expression level of TRADD was also remarkably increased when SCC25 cells were treated with 5 μM PLB for 48 hours. These results clearly show that PLB induces apoptosis by involving the FADD-mediated extrinsic pathway in SCC25 cells, and these data are in agreement with our proteomic findings.

PLB inhibits EMT and stemness in SCC25 cells
--------------------------------------------

EMT is a critical process involved in the invasion, metastasis, and stemness of cancer.[@b35-dddt-9-5511] EMT depends on a reduction in expression of cell adhesion molecules. Tight junctions function as complete barriers between epithelium and endothelium and contribute to the maintenance of cell polarity. Claudin and occludin proteins are integral structural and functional components of tight junctions.[@b36-dddt-9-5511],[@b37-dddt-9-5511] ZO-1, 2, and 3 are peripheral membrane adaptor proteins that link junctional transmem-brane proteins to the actin cytoskeleton.[@b38-dddt-9-5511]--[@b40-dddt-9-5511] Cadherins are a superfamily of transmembrane glycoproteins, which include N-, P-, R-, B-, and E-cadherins.[@b41-dddt-9-5511] E-cadherin is considered an active suppressor of invasion in many epithelial cancers.[@b42-dddt-9-5511] Cancer cells often have upregulated N-cadherin in addition to loss of E-cadherin.[@b43-dddt-9-5511] Furthermore, the cytoplasmic domain of classical cadherins interacts with β-catenin, γ-catenin, and p120 catenin.[@b44-dddt-9-5511],[@b45-dddt-9-5511] It is reported that snail can interact with β-catenin via Wnt signaling pathway.[@b46-dddt-9-5511] Herein, on the basis of the proteomic results ([Figure 8](#f8-dddt-9-5511){ref-type="fig"}), we verified the effect of PLB treatment on EMT-associated markers in SCC25 cells using Western blotting assay. Incubation of SCC25 cells with PLB resulted in a concentration- and time-dependent increase in the expression level of E-cadherin and a decrease in the expression level of N-cadherin ([Figure 9A--D](#f9-dddt-9-5511){ref-type="fig"}). There was a 1.2- and 1.8-fold increase in the expression of E-cadherin when treated with 1 and 5 μM PLB for 24 hours, respectively, whereas 5 μM PLB suppressed expression level of N-cadherin 23% (*P*\<0.05 or 0.001; [Figure 9A and C](#f9-dddt-9-5511){ref-type="fig"}). When SCC25 cells were treated with 5 μM PLB over 48 hours, the expression level of E-cadherin was increased 1.2-, 1.4-, and 1.8-fold after the treatment of 5 μM PLB for 6, 24, and 48 hours, respectively (*P*\<0.01 or 0.001; [Figure 9B and D](#f9-dddt-9-5511){ref-type="fig"}). The expression level of N-cadherin was decreased by 23.3% and 45.0% when SCC 25 cells were treated with 5 μM PLB for 24 and 48 hours, respectively (*P*\<0.05 or 0.001; [Figure 9B and D](#f9-dddt-9-5511){ref-type="fig"}).

In order to further examine the effect of PLB on EMT in SCC25 cells, we measured the expression level of several key regulators of E-cadherin. Snail and slug (both zinc finger transcriptional factors) together with TCF8/ZEB1 are suppressors of E-cadherin in EMT. PLB significantly reduced the expression level of snail and slug in SCC25 ([Figure 9A and C](#f9-dddt-9-5511){ref-type="fig"}). When SCC25 cells were treated with 5 μM PLB for 24 hours, the expression level of snail and slug was decreased by 46% and 41%, respectively ([Figure 9A and C](#f9-dddt-9-5511){ref-type="fig"}). Furthermore, PLB induced a time-dependent reduction in the expression level of TCF-8/ZEB1 in SCC25 cells. The expression level of TCF-8/ZEB1 was decreased by 22.0%, 27.0%, and 70.3% when SCC25 cells were treated with 5 μM PLB for 6, 24, and 48 hours, respectively ([Figure 9B and D](#f9-dddt-9-5511){ref-type="fig"}).

Vimentin is a type III intermediate filament protein in mesenchymal cells. β-Catenin can act as an integral component of a protein complex in adherens junctions that helps cells maintain epithelial layers, and β-catenin participates in the Wnt signaling pathway as a downstream target. In SCC25 cells, PLB inhibited the expression of vimentin in a concentration- and time-dependent manner. The expression level of vimentin was decreased by 19.3% and 24.7% when cells were treated with 1 and 5 μM PLB for 24 hours, respectively (*P*\<0.01; [Figure 9A and C](#f9-dddt-9-5511){ref-type="fig"}). Consistently, the expression level of vimentin was decreased by 21.0% and 51.3% when SCC25 cells were incubated with 5 μM PLB for 24 and 48 hours, respectively (*P*\<0.01 or 0.001; [Figure 9B and D](#f9-dddt-9-5511){ref-type="fig"}). There was also a significant reduction in the expression level of β-catenin in both the concentration and time course experiment when SCC25 cells were treated with 5 μM PLB. PLB at 5 μM markedly decreased the expression level of β-catenin by 24.7% with a 24-hour incubation period (*P*\<0.01; [Figure 9A and C](#f9-dddt-9-5511){ref-type="fig"}). Finally, the expression of tight junction proteins ZO-1 and claudin-1 were examined in SCC25 cells after the treatment of PLB. ZO-1 and -2 are required for tight junction formation and function. The effect of PLB on the expression of ZO-1 and claudin-1 in SCC25 cells increased significantly in a concentration- and time-dependent manner ([Figure 9A and B](#f9-dddt-9-5511){ref-type="fig"}). Treatment of cells with 5 μM PLB for 24 hours led to a 1.8- and 3.5-fold rise in the expression level of ZO-1 and claudin-1, compared to the control cells, respectively (*P*\<0.001; [Figure 9A and C](#f9-dddt-9-5511){ref-type="fig"}). These results from Western blotting assay verified our proteomic data.

In addition, there is increasing evidence showing that CSCs can display EMT characteristics such as loss of the adhesion protein E-cadherin. This relationship drives us to think about the stemness-attenuating effect of PLB in SCC25 cells. Therefore, we primarily conducted the Western blotting assay to examine the key stemness markers, including Oct-4, Bmi-1, Nanog, and Sox-2. Oct-4, also known as Oct-3, belongs to the POU (Pit-Oct-Unc) transcription factor family and plays an important role during early embryogenesis.[@b47-dddt-9-5511] Sox-2 is a member of the *Sox* gene family that encodes transcription factors and plays an important role in the maintenance of stemness.[@b48-dddt-9-5511] Nanog transcription factor cooperates with Oct-4 and Sox-2 and is identified as a key CSCs marker.[@b49-dddt-9-5511] Bmi-1 is a transcriptional repressor that belongs to the polycomb-group family of proteins that determine the proliferation and senescence of normal and CSCs.[@b50-dddt-9-5511] The Western blotting results showed that PLB significantly decreased the expression level of Oct-4, Sox-2, Nanog, and Bmi-1. Incubation of SCC25 cells with 5 μM PLB remarkably decreased the expression level of Oct-4, Sox-2, Nanog, and Bni-1 by 35.7%, 27.0%, 70.7%, and 38.3%, respectively, compared with the control cells (*P*\<0.001; [Figure 10A and C](#f10-dddt-9-5511){ref-type="fig"}). In a separate experiment, we evaluated the effect of different incubation times with 5 μM PLB. Totally, the expression levels of Bmi-1, Nanog, and Sox-2 were decreased significantly after 6 hours of incubation, while the Oct-4 expression level was decreased significantly after 24 hours of incubation ([Figure 10B and D](#f10-dddt-9-5511){ref-type="fig"}). These results indicate that PLB suppresses the stemness of human TSCC cells.

PLB induces intracellular ROS generation and regulates redox homeostasis via suppressing Nrf2-mediated oxidative signaling pathway in SCC25 cells
-------------------------------------------------------------------------------------------------------------------------------------------------

As shown in the proteomic results, PLB exhibited a regulating effect on intracellular redox homeostasis in SCC25 cells, which may possibly contribute to the cell cycle arresting, apoptosis inducing, EMT inhibiting, and stemness-attenuating effects of PLB. Herein, we examined the role of Nrf2-mediated signaling pathway in PLB's beneficial action in SCC25 cells. Nrf2, also known as Nfe2I2, is a nuclear factor that controls the expression of various detoxifying enzymes, ROS elimination proteins, drug transporters, and antiapoptotic proteins. Normally, Nrf2 is suppressed in the cytoplasm by the interaction with Kelch-like ECH-associated protein 1 (Keap1) and Cullin3. Once exposed to the antioxidant response element (ARE)-mediated inducers, Nrf2 will translocate to the nucleus where it forms a heterodimer with a small Maf protein and binds to other nuclear factors and initiates the transcription of antioxidative genes.[@b51-dddt-9-5511],[@b52-dddt-9-5511] As noted earlier, the proteomic results indicated that Nrf2-oxidative signaling pathway responded to the PLB treatment in SCC25 cells ([Figure 11](#f11-dddt-9-5511){ref-type="fig"}). Therefore, we analyzed this pathway using Western blotting assay. First, SCC25 cells were treated with 0.1, 1, and 5 μM PLB for 24 hours and their nuclear proteins were extracted. The results showed that the expression levels of nuclear (n)-Nrf2, NQO1, GST, and HSP90 were all decreased, while the expression level of cytosolic (c)-Nrf2 was increased in SCC25 cells, compared with the control cells ([Figure 12A](#f12-dddt-9-5511){ref-type="fig"}). The ratio of n-Nrf2 to c-Nrf2 was decreased by 13.3% and 37.0% when SCC25 cells were incubated with 1 and 5 μM PLB for 24 hours, respectively (*P*\<0.01 or 0.001; [Figure 12C](#f12-dddt-9-5511){ref-type="fig"}). In addition, the expression levels of c-Nrf2, n-Nrf2, NQO1, GST, and HSP90 were also examined with the treatment of 5 μM PLB over a 48-hour treatment period. The ratio of n-Nrf2 to c-Nrf2 was decreased by 28.3% and 39.0% when SCC25 cells were incubated with 5 μM PLB for 24 and 48 hours, respectively (*P*\<0.001; [Figure 12D](#f12-dddt-9-5511){ref-type="fig"}). The expression levels of NQO1, GST, and HSP90 were all markedly decreased (*P*\<0.05 or 0.001; [Figure 12D](#f12-dddt-9-5511){ref-type="fig"}). Taken together, the results show that Nrf2-oxidative signaling pathway is involved in the ROS-generation-inducing effect of PLB, contributing to the regulatory activities of PLB on intracellular redox homeostasis in SCC25 cells ([Figure 13](#f13-dddt-9-5511){ref-type="fig"}).

Relationship between PLB-induced ROS generation and PLB-mediated cell cycle arrest, apoptosis induction, EMT inhibition, and stemness attenuation
-------------------------------------------------------------------------------------------------------------------------------------------------

The relationship between PLB-induced ROS generation and PLB-mediated cell cycle arrest, apoptosis induction, EMT inhibition, and stemness attenuation was further examined in SCC25 cells with the application of ROS scavengers (NAC and GSH). SCC25 cells were treated with 5 μM PLB, 100 μM NAC, 1 mM GSH, 5 μM PLB plus 100 μM NAC, and 5 μM PLB plus 1 mM GSH, respectively. As shown in [Figures 14](#f14-dddt-9-5511){ref-type="fig"}[](#f15-dddt-9-5511){ref-type="fig"}--[16](#f16-dddt-9-5511){ref-type="fig"}, the cell cycle arresting, apoptosis inducing, EMT inhibiting, and stemness-attenuating effects of PLB were abolished by NAC and GSH. The percentage of cells in G~2~/M phase was decreased by 53.2% and 61.4% in SCC25 cells when cells were coincubated with NAC and PLB or GSH and PLB, compared to PLB-treated cells, respectively (*P*\<0.01 or 0.001; [Figure 14B](#f14-dddt-9-5511){ref-type="fig"}). In addition, in comparison to PLB-treated cells, NAC and GSH ablated PLB-induced apoptosis 53.3% and 55.6%, respectively (*P*\<0.001; [Figure 15B](#f15-dddt-9-5511){ref-type="fig"}). Furthermore, the expression of EMT and stemness representative markers were measured ([Figure 16](#f16-dddt-9-5511){ref-type="fig"}). Compared to PLB-treated cells, the expression level of E-cadherin was decreased by 30.4% and 36.2% when cells were cotreated with NAC and PLB or GSH and PLB, respectively (*P*\<0.001; [Figure 16A and B](#f16-dddt-9-5511){ref-type="fig"}). On the contrary, the expression level of N-cadherin, Oct-4, Bmi-1, and Nanog was increased when cells were coincubated with NAC and PLB or GSH and PLB ([Figure 16A and B](#f16-dddt-9-5511){ref-type="fig"}). However, the expression level of Sox-2 did not show statistical significance ([Figure 16A and B](#f16-dddt-9-5511){ref-type="fig"}). This may be partially ascribed to PLB-mediated other pathways that downregulate the Sox-2 level. Taken together, PLB-induced ROS generation may interact with the actions of PLB-mediated cell cycle arrest, apoptosis induction, EMT inhibition, and stemness attenuation.

Discussion
==========

TSCC remains one of the devastating malignancies in oral and maxillofacial tumors. TSCC is notorious for its lymphatic metastasis and relapse. Although sequential treatments are available, including radiotherapy, surgery, and chemotherapy, the therapeutic efficacy is not so optimistic.[@b1-dddt-9-5511] This is partially due to hyperactive cell survival pathways and radiotherapy/chemotherapy resistance.[@b53-dddt-9-5511],[@b54-dddt-9-5511] It is urgent to probe into the corresponding molecular alterations and seek novel effective drugs for TSCC treatment. PLB is an active naphthoquinone constituent isolated from the roots of *Plumbaginaceae* plants.[@b17-dddt-9-5511] It has been reported that PLB exhibits anticancer activities with minimal side effect in vitro and in vivo, which is greatly ascribed to its effects on multiple signaling pathways related to ROS generation, apoptosis, and autophagy.[@b23-dddt-9-5511],[@b55-dddt-9-5511],[@b56-dddt-9-5511] In this study, we employed a SILAC-based quantitative proteomic study to obtain a comprehensive view of the proteomic response to PLB treatment in TSCC cell line SCC25, and the findings have shown that PLB regulates a variety of functional protein molecules and signaling pathways involved in critical cellular processes. Further validation results have shown that PLB induces G~2~/M arrest and extrinsic apoptosis, but inhibits EMT and stemness via ROS generation through Nrf2-mediated oxidative signaling pathway in TSCC cell line SCC25 cells.

The SILAC-based proteomic approach can provide a system-level analysis to tackle the challenges in cancer treatment, such as chemoresistance. One study applied SILAC-based quantitative proteomic approach to analyze differences in protein expression level between parental hepatocellular carcinoma cell line HuH-7 and sorafenib-acquired resistance HuH-7 (HuH-7R) cells. Results indicated that galectin-1 is a predictive marker of sorafenib resistance and a downstream target of the Akt/mTOR/HIF-1a signaling pathway.[@b57-dddt-9-5511] The SILAC-based proteomic approach can also quantitatively evaluate the effect of a given compound or drug and identify its potential molecular targets and related signaling pathways.[@b58-dddt-9-5511]--[@b60-dddt-9-5511] For example, the SILAC-based proteomic approach was used to screen the therapeutic targets of histone deacetylases inhibitor vorinostat in human breast cancer MDA-MB-231 cell line, and the results found that 61 proteins were lysine acetylated by vironostat.[@b30-dddt-9-5511] This study demonstrated that PLB modulated a plethora of protein molecules, of which the expression levels of 143 protein molecules were increased while the levels of 255 protein molecules were decreased. Furthermore, 101 signaling pathways were potentially regulated by PLB in SCC25 cells. The following proteins are widely involved in cell survival, cell proliferation, redox homeostasis, cell metabolism, cell migration, and cell death: YWHAQ, PRKDC, YWHAG, YWHAE, YWHAH, YWHAB, YWHAZ, SFN, SKP1, CDK1, ACIN1, CAPNS1, MAPK1, RRAS, LMNA, CAPN2, SPTAN1, CYCS, PARP1, AIFM1, FADD, ACTB, ACTA1, ACTG1, ACTN1, ACTN4, ACTR3, ARPC1B, CTNNA1, CTNND1, DNM1L, EGFR, IQGAP1, JUP, MYH9, RAB7A, RHO1, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B, VAL, VCL, ZYX, CBR, DNAJA2, GSTP1, NQO1, HSP90AA1, PPIB, SOD1, STIP1, and VCP. The network of signaling pathways was mainly related to cell cycle distribution, cell migration, redox hemostasis, and cell death. The top ten targeted signaling pathways were EIF2 signaling pathway, regulation of eIF4 and p70S6K signaling, remodeling of epithelial adherens junctions pathway, mTOR signaling pathway, protein ubiquitination pathway, Nrf2-mediated oxidative stress response signaling pathway, epithelial adherens junction signaling pathway, caveolar-mediated endocytosis signaling pathway, RhoA signaling pathway, and oxidative phosphorylation pathway. The proteomic results indicate that PLB may target these molecules and related signaling pathways to elicit its anticancer effects in the treatment of TSCC. Notably, we have observed a differential effect of PLB on turmoral and nontumoral cells, with a higher half-maximal inhibitory concentration toward to nontumoral cells than that to the corresponding tumoral cells,[@b20-dddt-9-5511] which renders PLB a promising anticancer drug candidate.

Subsequently, we further validated the proteomic responses to PLB in SCC25 cells. We found that PLB induced G~2~/M arrest in SCC25 cells in a concentration- and time-dependent manner. Meanwhile, the expression level of key regulators of G~2~/M phase, such as cdc2, cyclin B1, and cdc25, were decreased after the treatment of PLB. It has been reported that cell cycle progression is tightly regulated by cyclins and CDKs.[@b61-dddt-9-5511] The complex formed by the association of CDK1/cdc2 and Cyclin B1 plays a major role in the entry of cells into mitosis. Phosphorylation of CDK1/cdc2 at Thr161 by CDK-activating kinase is essential for CDK1/cdc2 kinase activity. The process of the CDK1/cdc2 phosphorylation and dephosphorylation are mediated by the nuclear kinase Wee1 and the dual-specificity phosphatase cdc25. Wee1 can stop mitosis by inhibiting the CDK1/cdc2 phosphorylation, while cdc25 can help entry into mitosis by eliminating the inhibitory phosphorylation.[@b61-dddt-9-5511] Thus, taking the proteomic, flow cytometric, and Western blotting results into consideration, PLB-induced cell cycle arrest may be mediated through the regulation of key modulators controlling the G~2~/M check point in SCC25 cells.

Apoptosis is a conserved physiological mechanism that is important during embryogenesis and homeostasis of tissue. Dysregulated apoptosis has been implicated in many diseases including cancer.[@b62-dddt-9-5511] The successful execution of apoptosis is crucial for many chemotherapy drugs.[@b63-dddt-9-5511] It is widely accepted that there are two types of apoptosis: intrinsic apoptosis and extrinsic apoptosis. Mitochondrial disruption and the subsequent cytochrome c release can initiate the caspase-dependent apoptosis. Bcl-2 family plays an important role during this process.[@b64-dddt-9-5511],[@b65-dddt-9-5511] Previously, our findings showed that PLB triggered the mitochondrial-mediated apoptosis in SCC25 cells.[@b20-dddt-9-5511] In this study, the proteomic study showed that PLB regulated mitochondrial function and death receptor signaling pathway. We found that PLB could induce FADD-mediated extrinsic apoptosis in SCC25 cells. The proteomic results hinted that PLB regulated the death receptor signaling and that the protein molecule FADD was upregulated by PLB. FADD is a key adaptor protein for death receptor-mediated apoptosis. The death domain of FADD binds to the death domain of death receptor. Subsequently, procaspase-8 is recruited and caspase 3, 6, and 7 are cleaved. Finally, apoptosis is induced; and both intrinsic and extrinsic apoptosis converge into the cleavage of caspase 3. TRADD is a tumor necrosis factor receptor 1 (TNFR1) associated signal transducer that enhances association of FADD with TNFR1.[@b66-dddt-9-5511],[@b67-dddt-9-5511] DR5, also known as TRAIL-R2, can bind to adaptor molecules FADD and TRADD.[@b68-dddt-9-5511] In this study, we found that PLB increased the level of FADD, TRADD, and DR5. This indicated the extrinsic apoptosis-inducing effect of PLB in SCC25. Together with the results from our previous paper,[@b20-dddt-9-5511] it seems that PLB can efficiently induce both intrinsic and extrinsic apoptosis in SCC25 cells.

TSCC is notorious for its metastasis and relapse, and acquisition of EMT and induction of CSC-like properties are inevitably responsible for the metastasis and relapse.[@b69-dddt-9-5511] EMT is a highly conserved biological process that converts epithelial cells into mesenchymal cells via the modulation of various transcription factors.[@b70-dddt-9-5511]--[@b73-dddt-9-5511] EMT has been classified into three types according to specific physiological context. Type I EMT plays an important role in embryogenesis and organ development. Type II EMT functions in wound healing and tissue regeneration. Type III EMT, the one we focus on, is involved in cancer metastasis and CSC formation.[@b35-dddt-9-5511],[@b74-dddt-9-5511] The EMT process is characterized by loss of epithelial markers such as E-cadherin, claudin, and occludin, and acquisition of mesenchymal markers such as N-cadherin, vimentin, snail, slug, and ZO-1.[@b75-dddt-9-5511],[@b76-dddt-9-5511] Many signaling pathways, such as Wnt, TGF-β, and STAT3, can mediate the EMT process via activating a plethora of transcriptional regulators of mesenchymal markers.[@b75-dddt-9-5511],[@b76-dddt-9-5511] Furthermore, CSCs can display EMT characteristics such as loss of adhesion protein E-cadherin.[@b11-dddt-9-5511] Static CSCs that have moved to distant sites might be responsible for metastases and relapse, especially after curative surgical treatment of a primary tumor.[@b77-dddt-9-5511] Seminal findings demonstrate that EMT activators, such as Twist1 and Prrx1, can serve as a direct molecular link between EMT and stemness.[@b78-dddt-9-5511],[@b79-dddt-9-5511] Our proteomic study showed that PLB could regulate the epithelial adherens junctions pathway in SCC25 cells. The Western blotting assay validated that PLB could increase the expression level of E-cadherin and decrease the level of N-cadherin in SCC25 cells. Furthermore, we examined other key regulators of EMT. We found that PLB significantly reduced the expression level of snail, slug, TCF-8/ZEB1, β-catenin, and vimentin, while increasing the expression level of claudin-1 and ZO-1. All these implied the EMT-inhibiting role of PLB in SCC25 cells. Subsequently, CSCs markers were also measured, and the expression levels of Oct-4, Bmi-1, Nanog, and Sox-2 were all found to be decreased by PLB in a concentration- and time-dependent manner in SCC25 cells. Taken together, PLB can inhibit EMT and attenuate stemness in SCC25 cells. We can speculate that there are interconnections between EMT and stemness, such as the loss of E-cadherin. Given that PLB can regulate the key factors in EMT, the stemness property may more or less be affected. However, the exact network between EMT and stemness needs further investigation. Importantly, it has been reported that ROS may link the EMT and stemness via glucose metabolism.[@b80-dddt-9-5511] In our previous paper,[@b20-dddt-9-5511] we found that PLB can efficiently induce ROS generation, which can be abolished by ROS scavengers NAC and GSH. On the basis of the results of the present proteomic analysis, PLB can efficiently regulate the Nrf2-mediated oxidative stress response signaling pathway. Nrf2, also known as Nfe2I2, is a nuclear factor that controls the expression of various detoxifying enzymes, ROS elimination proteins, drug transporters, and antiapoptotic proteins. Normally, Nrf2 is suppressed in the cytoplasm by combination with Keap1 and Cullin3. Once exposed to the ARE-mediated inducers, Nrf2 will translocate to the nucleus where it forms a heterodimer with a small Maf protein and binds to other nuclear factors and initiates the transcription of antioxidative genes.[@b51-dddt-9-5511],[@b52-dddt-9-5511] The Western blotting results showed that the ratio of n-Nrf2 to c-Nrf2 was significantly decreased. Furthermore, the downstream effectors NQO1, GST, and HSP90 were examined. These effectors are involved in ROS elimination and detoxification.[@b81-dddt-9-5511]--[@b83-dddt-9-5511] Results showed that PLB can decrease the expression level of NQO1, GST, and HSP90 in SCC25 cells. We can carefully draw a conclusion that PLB can kill TSCC cells via ROS generation and attenuation of ROS elimination factors. Finally, we employed the ROS scavengers NAC and GSH to further examine the effect of PLB in cell cycle arrest, apoptosis induction, EMT inhibition, and stemness attenuation. Interestingly, results showed that the cell cycle arresting, apoptosis inducing, EMT inhibiting, and stemness-attenuating effect of PLB can be efficiently abolished by NAC and GSH. This highlights the ROS-generation-inducing effect of PLB as an upstream effector to regulate other downstream biological activities such as cell cycle arrest and apoptosis.

In summary, the quantitative SILAC-based proteomic approach showed that PLB inhibited cell proliferation, activated death receptor-mediated apoptotic pathway, remodeled epithelial adherens junctions pathway, and increased intracellular level of ROS via Nrf2-mediated oxidative stress response signaling pathway in human SCC25 cells involving a number of key functional proteins. This study may provide a clue to fully identify the molecular targets and elucidate the underlying mechanisms of PLB in the treatment of TSCC.
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![Proteomic analysis reveals a network of signaling pathways regulated by PLB in SCC25 cells.\
**Notes:** A network of signaling pathways was analyzed by IPA according to the 398 molecules and 101 related pathways that were regulated by PLB in SCC25 cells.\
**Abbreviations:** IPA, Ingenuity Pathway Analysis; PLB, plumbagin.](dddt-9-5511Fig1){#f1-dddt-9-5511}

![PLB regulates cell cycle at G~2~/M checkpoint in SCC25 cells.\
**Notes:** SCC25 cells were treated with 5 μM PLB for 24 hours and the protein samples were subject to quantitative proteomic analysis. Red indicates upregulation; green indicates a downregulation. The intensity of green and red molecule colors indicates the degree of down- or upregulation, respectively. Solid arrows indicate direct interaction.\
**Abbreviations:** PLB, plumbagin; UV, ultraviolet.](dddt-9-5511Fig2){#f2-dddt-9-5511}

![PLB induces G~2~/M arrest in SCC25 cells.\
**Notes:** Cell cycle distribution of SCC25 cells after the treatment of PLB in the concentration and time course experiments. (**A**) Representative flow cytometric plots of cell cycle distribution of SCC25 cells and (**B**) bar graphs showing the percentage of SCC25 cells in G~1~, S, and G~2~/M phases after the treatment of 0.1, 1, and 5 μM PLB for 24 hours. (**C**) Representative flow cytometric plots of cell cycle distribution of SCC25 cells and (**D**) bar graphs showing the percentage of SCC25 cells in G~1~, S and G~2~/M phases after the treatment of 5 μM PLB for 6, 24, and 48 hours. Data are the mean ± SD of three independent experiments. \**P*\<0.05; \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.\
**Abbreviations:** PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation; PI, propidium iodide.](dddt-9-5511Fig3){#f3-dddt-9-5511}

###### 

PLB regulates the expression of CDK1/cdc2, cyclin B1, and cdc25 in SCC25 cells.

**Notes:** SCC25 cells were treated with PLB in the concentration and time course experiments and the protein samples were subject to Western blotting assay. (**A**) Representative blots of CDK1/cdc2, cyclin B1, and cdc25 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**B**) representative blots of CDK1/cdc2, cyclin B1, and cdc25 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. (**C**) Bar graphs showing the relative levels of CDK1/cdc2, cyclin B1, and cdc25 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**D**) bar graphs showing the relative level of CDK1/cdc2, cyclin B1, and cdc25 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. Data are the mean ± SD of three independent experiments. \**P*\<0.05; \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.

**Abbreviations:** PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.
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![PLB regulates death receptor signaling in SCC25 cells.\
**Notes:** SCC25 cells were treated with 5 μM PLB for 24 hours and the protein samples were subject to quantitative proteomic analysis. Red indicates upregulation; green indicates downregulation. The intensity of green and red molecule colors indicates the degree of down- or upregulation, respectively. Solid arrows indicate direct interaction and dashed arrows indicate indirect interaction. The arrow with white head indicates translocation. The arrow with gray head indicates activation, causation, expression, localization, membership, modification, molecular cleavage, phosphorylation, protein-DNA interactions, protein-RNA interactions, regulation of binding, transcription.\
**Abbreviation:** PLB, plumbagin.](dddt-9-5511Fig5){#f5-dddt-9-5511}

![PLB induces apoptosis in SCC25 cells.\
**Notes:** Apoptosis induction effect of PLB in SCC25 cells was examined. (**A**) Representative flow cytometric plots of apoptosis in SCC25 cells and (**B**) bar graphs showing the percentage of total apoptosis in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours. (**C**) Representative flow cytometric plots of apoptosis in SCC25 cells and (**D**) bar graphs showing the total apoptosis in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. Data are the mean ± SD of three independent experiments. \**P*\<0.05; \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.\
**Abbreviations:** PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.](dddt-9-5511Fig6){#f6-dddt-9-5511}

###### 

PLB regulates the expression of FADD, TRADD, and DR5 in SCC25 cells.

**Notes:** SCC25 cells were treated with PLB in the concentration and time course experiments and protein samples were subject to Western blotting assay. (**A**) Representative blots of FADD, TRADD, and DR5 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**B**) representative blots of FADD, TRADD, and DR5 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. (**C**) Bar graphs showing the relative level of FADD, TRADD, and DR5 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**D**) bar graphs showing the relative level of FADD, TRADD, and DR5 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. Data are the mean ± SD of three independent experiments. \**P*\<0.05; \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.

**Abbreviations:** PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation; FADD, Fas (TNFRSF6)-associated via death domain; TRADD, TNF1 receptor-associated death domain.
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![PLB regulates remodeling of epithelial adherens junctions pathway in SCC25 cells.\
**Notes:** SCC25 cells were treated with 5 μM PLB for 24 hours and the protein samples were subject to quantitative proteomic analysis. Red indicates upregulation; green indicates downregulation. The intensity of green and red molecule colors indicates the degree of down or upregulation, respectively. Solid arrows indicate direct interaction. The arrow with white head indicates translocation. The arrow with gray head indicates activation, causation, expression, localization, membership, modification, molecular cleavage, phosphorylation, protein-DNA interactions, protein-RNA interactions, regulation of binding, transcription.\
**Abbreviation:** PLB, plumbagin.](dddt-9-5511Fig8){#f8-dddt-9-5511}

###### 

PLB regulates the expression of EMT-related markers in SCC25 cells.

**Notes:** SCC25 cells were treated with PLB in the concentration and time course experiments and protein samples were subject to Western blotting assay. (**A**) Representative blots of E-cadherin, N-cadherin, snail, slug, TCF8/ZEB1, vimentin, β-catenin, ZO-1, and claudin-1 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours; (**B**) representative blots of E-cadherin, N-cadherin, snail, slug, TCF8/ZEB1, vimentin, β-catenin, ZO-1, and claudin-1 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. (**C**) Bar graphs showing the relative level of E-cadherin, N-cadherin, snail, slug, TCF8/ZEB1, vimentin, β-catenin, ZO-1, and claudin-1 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**D**) bar graphs showing the relative level of E-cadherin, N-cadherin, snail, slug, TCF8/ZEB1, vimentin, β-catenin, ZO-1, and claudin-1 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. Data are the mean ± SD of three independent experiments. \**P*\<0.05; \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.

**Abbreviations:** PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.
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![PLB regulates the expression of stemness markers in SCC25 cells.\
**Notes:** SCC25 cells were treated with PLB in the concentration and time course experiments and protein samples were subject to Western blotting assay. (**A**) Representative blots of Oct-4, Bmi-1, Nanog, and Sox-2 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**B**) representative blots of Oct-4, Bmi-1, Nanog, and Sox-2 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. (**C**) Bar graphs showing the relative levels of Oct-4, Bmi-1, Nanog, and Sox-2 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**D**) bar graphs showing the relative levels of Oct-4, Bmi-1, Nanog, and Sox-2 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. Data are the mean ± SD of three independent experiments. \**P*\<0.05; \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.\
**Abbreviations:** PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.](dddt-9-5511Fig10){#f10-dddt-9-5511}

![PLB regulates Nrf2 oxidative signaling pathway in SCC25 cells.\
**Notes:** SCC25 cells were treated with 5 μM PLB for 24 hours and the protein samples were subject to quantitative proteomic analysis. Red indicates upregulation; green indicates downregulation. The intensity of green and red molecule colors indicates the degree of down or upregulation, respectively. Solid arrows indicate direct interaction and dashed arrows indicate indirect interaction.\
**Abbreviations:** PLB, plumbagin; UV, ultraviolet.](dddt-9-5511Fig11){#f11-dddt-9-5511}

![PLB regulates the expression of Nrf2, NQO1, GST, and HSP90 in SCC25 cells.\
**Notes:** SCC25 cells were treated with PLB in the concentration and time course experiments and protein samples were subject to Western blotting assay. (**A**) Representative blots of c-Nrf2, n-Nrf2, NQO1, GST, and HSP90 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**B**) representative blots of Nrf2, NQO1, GST, and HSP90 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. (**C**) Bar graphs showing the relative level of Nrf2, NQO1, GST, and HSP90 in SCC25 cells after the treatment of 0.1, 1, and 5 μM PLB for 24 hours, and (**D**) bar graphs showing the relative levels of Nrf2, NQO1, GST, and HSP90 in SCC25 cells after the treatment of 5 μM PLB for 6, 24, and 48 hours. Data are the mean ± SD of three independent experiments. \**P*\<0.05; \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.\
**Abbreviations:** PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.](dddt-9-5511Fig12){#f12-dddt-9-5511}

![Schematic diagram shows that PLB regulates the Nrf2-mediated oxidative signaling pathway and its downstream proteins NQO1, GST, and HSP90 in SCC25 cells.\
**Abbreviations:** ROS, reactive oxygen species; GST, glutathione S-transferase.](dddt-9-5511Fig13){#f13-dddt-9-5511}

![The effect of ROS scavengers NAC and GSH in PLB-induced G~2~/M arrest in SCC25 cells.\
**Notes:** (**A**) Representative flow cytometric plots of cell cycle distribution of SCC25 and (**B**) bar graphs showing the percentage of SCC25 cells in G~1~, S and G~2~/M phases after the treatment of 5 μM PLB, 100 μM NAC, 1 mM GSH, 5 μM PLB plus 100 μM NAC, and 5 μM PLB plus 1 mM GSH for 24 hours. Data are the mean ± SD of three independent experiments. \*\**P*\<0.01; and \*\*\**P*\<0.001 by one-way ANOVA.\
**Abbreviations:** ROS, reactive oxygen species; NAC, *N*-acetyl-[l]{.smallcaps}-cysteine; GSH, [l]{.smallcaps}-glutathione; PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.](dddt-9-5511Fig14){#f14-dddt-9-5511}

![The effect of ROS scavengers NAC and GSH in PLB-induced apoptosis in SCC25 cells.\
**Notes:** (**A**) Representative flow cytometric plots of apoptosis in SCC25 and (**B**) bar graphs showing the apoptotic percentage of SCC25 cells after the treatment of 5 μM PLB, 100 μM NAC, 1 mM GSH, 5 μM PLB plus 100 μM NAC, and 5 μM PLB plus 1 mM GSH for 24 hours. Data are the mean ± SD of three independent experiments. \*\*\**P*\<0.001 by one-way ANOVA.\
**Abbreviations:** ROS, reactive oxygen species; NAC, *N*-acetyl-[l]{.smallcaps}-cysteine; GSH, [l]{.smallcaps}-glutathione; PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.](dddt-9-5511Fig15){#f15-dddt-9-5511}

###### 

The effect of ROS scavengers NAC and GSH in PLB-mediated EMT inhibition and stemness attenuation in SCC25 cells.

**Notes:** (**A**) Representative blots of E-cadherin, N-cadherin, Oct-4, Bmi-1, Nanog, and Sox-2 in SCC25 cells and (**B**) bar graphs showing the relative level of E-cadherin, N-cadherin, Oct-4, Bmi-1, Nanog, and Sox-2 in SCC25 cells after the treatment of 5 μM PLB, 100 μM NAC, 1 mM GSH, 5 μM PLB plus 100 μM NAC, and 5 μM PLB plus 1 mM GSH for 24 hours. Data are the mean ± SD of three independent experiments. \*\*\**P*\<0.001 by one-way ANOVA.

**Abbreviations:** ROS, reactive oxygen species; NAC, *N*-acetyl-[l]{.smallcaps}-cysteine; GSH, [l]{.smallcaps}-glutathione; EMT, epithelial to mesenchymal transition; PLB, plumbagin; ANOVA, analysis of variance; SD, standard deviation.

![](dddt-9-5511Fig16)

![](dddt-9-5511Fig16a)

###### 

Proteins upregulated by PLB in SCC25 cells

  Fold change   ID       Symbol        Entrez gene name                                                                                                             Location              Type(s)
  ------------- -------- ------------- ---------------------------------------------------------------------------------------------------------------------------- --------------------- -------------------------
  16.699        Q9Y4L1   HYOU1         Hypoxia upregulated 1                                                                                                        Cytoplasm             Other
  6.339         Q86UP2   KTN1          Kinectin 1 (kinesin receptor)                                                                                                Plasma membrane       Transmembrane receptor
  5.171         P07996   THBS1         Thrombospondin 1                                                                                                             Extracellular space   Other
  4.993         Q9H3K6   BOLA2/BC      BolA family member 2                                                                                                         Cytoplasm             Other
  4.304         Q9NY33   DPP3          Dipeptidyl-peptidase 3                                                                                                       Cytoplasm             Peptidase
  3.861         P12277   CKB           Creatine kinase, brain                                                                                                       Cytoplasm             Kinase
  3.794         P14866   HNRNPL        Heterogeneous nuclear ribonucleoprotein L                                                                                    Nucleus               Other
  3.14          H0Y4R1   IMPDH2        IMP (inosine 5′-monophosphate) dehydrogenase 2                                                                               Cytoplasm             Enzyme
  3.022         Q9NZB2   FAM120A       Family with sequence similarity 120A                                                                                         Cytoplasm             Other
  2.667         Q9P2E9   RRBP1         Ribosome binding protein 1                                                                                                   Cytoplasm             Other
  2.61          Q9BQE3   TUBA1C        Tubulin, alpha 1c                                                                                                            Cytoplasm             Other
  2.289         P62136   PPP1CA        Protein phosphatase 1, catalytic subunit, alpha isozyme                                                                      Cytoplasm             Phosphatase
  2.164         P23284   PPIB          Peptidylprolyl isomerase B (cyclophilin B)                                                                                   Cytoplasm             Enzyme
  2.142         P14923   JUP           Junction plakoglobin                                                                                                         Plasma membrane       Other
  2.136         P38646   HSPA9         Heat shock 70 kDa protein 9 (mortalin)                                                                                       Cytoplasm             Other
  2.052         C9JZR2   CTNND1        Catenin (cadherin-associated protein), delta 1                                                                               Nucleus               Other
  1.978         O43852   CALU          Calumenin                                                                                                                    Cytoplasm             Other
  1.871         Q01082   SPTBN1        Spectrin, beta, non-erythrocytic 1                                                                                           Plasma membrane       Other
  1.864         P50454   SERPINH1      Serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)                          Extracellular space   Other
  1.753         Q13751   LAMB3         Laminin, beta 3                                                                                                              Extracellular space   Transporter
  1.742         Q13158   FADD          Fas (TNFRSF6)-associated via death domain                                                                                    Cytoplasm             Other
  1.732         Q9UHX1   PUF60         Poly-U binding splicing factor 60 kDa                                                                                        Nucleus               Other
  1.718         P32320   CDA           Cytidine deaminase                                                                                                           Nucleus               Enzyme
  1.695         P05556   ITGB1         Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)                                 Plasma membrane       Transmembrane receptor
  1.682         P04844   RPN2          Ribophorin II                                                                                                                Cytoplasm             Enzyme
  1.615         P17844   DDX5          DEAD (Asp-Glu-Ala-Asp) box helicase 5                                                                                        Nucleus               Enzyme
  1.612         O14579   COPE          Coatomer protein complex, subunit epsilon                                                                                    Cytoplasm             Transporter
  1.581         Q13409   DYNC1/2       Dynein, cytoplasmic 1, intermediate chain 2                                                                                  Cytoplasm             Other
  1.576         Q13753   LAMC2         Laminin, gamma 2                                                                                                             Extracellular space   Other
  1.556         Q96QK1   VPS35         Vacuolar protein sorting 35 (*S. cerevisiae*)                                                                                Cytoplasm             Transporter
  1.536         P04181   OAT           Ornithine aminotransferase                                                                                                   Cytoplasm             Enzyme
  1.535         E7EPN9   PRRC2C        Proline-rich coiled-coil 2C                                                                                                  Other                 Other
  1.534         P22102   GART          Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase   Cytoplasm             Enzyme
  1.518         P45974   USP5          Ubiquitin specific peptidase 5 (isopeptidase T)                                                                              Cytoplasm             Peptidase
  1.508         P62263   RPS14         Ribosomal protein S14                                                                                                        Cytoplasm             Translation regulator
  1.474         P08779   KRT16         Keratin 16                                                                                                                   Cytoplasm             Other
  1.463         P62701   RPS4X         Ribosomal protein S4, X-linked                                                                                               Cytoplasm             Other
  1.454         P31939   ATIC          5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase                                           Cytoplasm             Enzyme
  1.442         Q6NZI2   PTRF          Polymerase I and transcript release factor                                                                                   Nucleus               Transcription regulator
  1.439         B1AH77   RAC2          Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)                                      Cytoplasm             Enzyme
  1.412         P05787   KRT8          Keratin 8                                                                                                                    Cytoplasm             Other
  1.41          P60228   EIF3E         Eukaryotic translation initiation factor 3, subunit E                                                                        Cytoplasm             Other
  1.408         A1A4Z1   IQUB          IQ motif and ubiquitin domain containing                                                                                     Cytoplasm             Other
  1.405         Q15459   SF3A1         Splicing factor 3a, subunit 1, 120 kDa                                                                                       Nucleus               Other
  1.404         O95817   BAG3          BCL2-associated athanogene 3                                                                                                 Cytoplasm             Other
  1.398         F5GWP8   KRT17         Keratin 17                                                                                                                   Cytoplasm             Other
  1.396         O00303   EIF3F         Eukaryotic translation initiation factor 3, subunit F                                                                        Cytoplasm             Translation regulator
  1.388         P11021   HSPA5         Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa)                                                              Cytoplasm             Enzyme
  1.374         Q07065   CKAP4         Cytoskeleton-associated protein 4                                                                                            Cytoplasm             Other
  1.367         P49411   TUFM          Tu translation elongation factor, mitochondrial                                                                              Cytoplasm             Translation regulator
  1.363         K7EK07   H3F3A/H3F3B   H3 histone, family 3A                                                                                                        Nucleus               Other
  1.36          P15924   DSP           Desmoplakin                                                                                                                  Plasma membrane       Other
  1.357         P20700   LMNB1         Lamin B1                                                                                                                     Nucleus               Other
  1.324         P14625   HSP90B1       Heat shock protein 90 kDa beta (Grp94), member 1                                                                             Cytoplasm             Other
  1.315         F8VY35   NAP1L1        Nucleosome assembly protein 1-like 1                                                                                         Nucleus               Other
  1.314         F8VZX2   PCBP2         Poly(rC) binding protein 2                                                                                                   Nucleus               Other
  1.302         P42224   STAT1         Signal transducer and activator of transcription 1, 91 kDa                                                                   Nucleus               Transcription regulator
  1.286         P35613   BSG           Basigin (Ok blood group)                                                                                                     Plasma membrane       Transporter
  1.268         Q9UQ80   PA2G4         Proliferation-associated 2G4, 38 kDa                                                                                         Nucleus               Transcription regulator
  1.258         K7EJ78   RPS15         Ribosomal protein S15                                                                                                        Cytoplasm             Other
  1.254         F8VPF3   PDE6H         Phosphodiesterase 6H, cGMP-specific, cone, gamma                                                                             Cytoplasm             Enzyme
  1.252         P32969   RPL9          Ribosomal protein L9                                                                                                         Cytoplasm             Other
  1.243         P09972   ALDOC         Aldolase C, fructose-bisphosphate                                                                                            Cytoplasm             Enzyme
  1.243         P26038   MSN           Moesin                                                                                                                       Plasma membrane       Other
  1.234         P68366   TUBA4A        Tubulin, alpha 4a                                                                                                            Cytoplasm             Other
  1.232         P23526   AHCY          Adenosylhomocysteinase                                                                                                       Cytoplasm             Enzyme
  1.224         P31949   S100A11       S100 calcium binding protein A11                                                                                             Cytoplasm             Other
  1.22          R4GNH3   PSMC3         Proteasome (prosome, macropain) 26S subunit, ATPase, 3                                                                       Nucleus               Transcription regulator
  1.215         Q12906   ILF3          Interleukin enhancer binding factor 3, 90 kDa                                                                                Nucleus               Transcription regulator
  1.214         P46777   RPL5          Ribosomal protein L5                                                                                                         Cytoplasm             Other
  1.21          H0YA96   HNRNPD        Heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)                                     Nucleus               Transcription regulator
  1.209         P22314   UBA1          Ubiquitin-like modifier activating enzyme 1                                                                                  Cytoplasm             Enzyme
  1.199         P02786   TFRC          Transferrin receptor                                                                                                         Plasma membrane       Transporter
  1.198         P02545   LMNA          Lamin A/C                                                                                                                    Nucleus               Other
  1.17          Q08211   DHX9          DEAH (Asp-Glu-Ala-His) box helicase 9                                                                                        Nucleus               Enzyme
  1.163         P31153   MAT2A         Methionine adenosyltransferase II, alpha                                                                                     Cytoplasm             Enzyme
  1.162         P55072   VCP           Valosin containing protein                                                                                                   Cytoplasm             Enzyme
  1.16          P62979   RPS27A        Ribosomal protein S27a                                                                                                       Cytoplasm             Other
  1.16          P31947   SFN           Stratifin                                                                                                                    Cytoplasm             Other
  1.159         P23381   WARS          Tryptophanyl-tRNA synthetase                                                                                                 Cytoplasm             Enzyme
  1.154         P46940   IQGAP1        IQ motif containing GTPase activating protein 1                                                                              Cytoplasm             Other
  1.153         Q13177   PAK2          p21 protein (Cdc42/Rac)-activated kinase 2                                                                                   Cytoplasm             Kinase
  1.148         Q9Y446   PKP3          Plakophilin 3                                                                                                                Plasma membrane       Other
  1.147         H0YLC2   PSMA4         Proteasome (prosome, macropain) subunit, alpha type, 4                                                                       Cytoplasm             Peptidase
  1.144         P25705   ATP5A1        ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle                                     Cytoplasm             Transporter
  1.143         Q14697   GANAB         Glucosidase, alpha; neutral AB                                                                                               Cytoplasm             Enzyme
  1.137         P06576   ATP5B         ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide                                                    Cytoplasm             Transporter
  1.136         P07355   ANXA2         Annexin A2                                                                                                                   Plasma membrane       Other
  1.136         Q99460   PSMD1         Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1                                                                   Cytoplasm             Other
  1.133         P07858   CTSB          Cathepsin B                                                                                                                  Cytoplasm             Peptidase
  1.129         Q9UMS4   PRPF19        Pre-mRNA processing factor 19                                                                                                Nucleus               Enzyme
  1.127         P31948   STIP1         Stress-induced phosphoprotein 1                                                                                              Cytoplasm             Other
  1.126         P05783   KRT18         Keratin 18                                                                                                                   Cytoplasm             Other
  1.125         P20618   PSMB1         Proteasome (prosome, macropain) subunit, beta type, 1                                                                        Cytoplasm             Peptidase
  1.123         P30101   PDIA3         Protein disulfide isomerase family A, member 3                                                                               Cytoplasm             Peptidase
  1.122         P04083   ANXA1         Annexin A1                                                                                                                   Plasma membrane       Enzyme
  1.115         Q96FW1   OTUB1         OTU deubiquitinase, ubiquitin aldehyde binding 1                                                                             Cytoplasm             Enzyme
  1.115         P55735   SEC13         SEC13 homolog (*S. cerevisiae*)                                                                                              Cytoplasm             Transporter
  1.111         P09936   UCHL1         Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)                                                            Cytoplasm             Peptidase
  1.108         O60506   SYNCRIP       Synaptotagmin binding, cytoplasmic RNA interacting protein                                                                   Nucleus               Other
  1.104         P02533   KRT14         Keratin 14                                                                                                                   Cytoplasm             Other
  1.103         P36952   SERPINB5      Serpin peptidase inhibitor, clade B (ovalbumin), member 5                                                                    Extracellular space   Other
  1.103         O43399   TPD52L2       Tumor protein D52-like 2                                                                                                     Cytoplasm             Other
  1.099         P50991   CCT4          Chaperonin containing TCP1, subunit 4 (delta)                                                                                Cytoplasm             Other
  1.096         P11142   HSPA8         Heat shock 70 kDa protein 8                                                                                                  Cytoplasm             Enzyme
  1.096         P40926   MDH2          Malate dehydrogenase 2, NAD (mitochondrial)                                                                                  Cytoplasm             Enzyme
  1.096         P31946   YWHAB         Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta                                                 Cytoplasm             Transcription regulator
  1.094         Q92597   NDRG1         N-myc downstream regulated 1                                                                                                 Nucleus               Kinase
  1.086         H7C5W9   ATP2A2        ATPase, Ca^2+^ transporting, cardiac muscle, slow twitch 2                                                                   Cytoplasm             Transporter
  1.086         P13489   RNH1          Ribonuclease/angiogenin inhibitor 1                                                                                          Cytoplasm             Other
  1.083         P31930   UQCRC1        Ubiquinol-cytochrome c reductase core protein I                                                                              Cytoplasm             Enzyme
  1.08          P17655   CAPN2         Calpain 2, (m/II) large subunit                                                                                              Cytoplasm             Peptidase
  1.08          P34932   HSPA4         Heat shock 70 kDa protein 4                                                                                                  Cytoplasm             Other
  1.076         P62241   RPS8          Ribosomal protein S8                                                                                                         Cytoplasm             Other
  1.071         P13647   KRT5          Keratin 5                                                                                                                    Cytoplasm             Other
  1.07          P02538   KRT6A         Keratin 6A                                                                                                                   Other                 Other
  1.058         P61981   YWHAG         Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma                                                Cytoplasm             Other
  1.057         P04075   ALDOA         Aldolase A, fructose-bisphosphate                                                                                            Cytoplasm             Enzyme
  1.053         Q96AG4   LRRC59        Leucine rich repeat containing 59                                                                                            Cytoplasm             Other
  1.05          P23219   PTGS1         Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)                                        Cytoplasm             Enzyme
  1.05          P27348   YWHAQ         Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta                                                Cytoplasm             Other
  1.046         P00387   CYB5R3        Cytochrome b5 reductase 3                                                                                                    Cytoplasm             Enzyme
  1.046         Q9UL46   PSME2         Proteasome (prosome, macropain) activator subunit 2 (PA28 beta)                                                              Cytoplasm             Peptidase
  1.037         P06748   NPM1          Nucleophosmin (nucleolar phosphoprotein B23, numatrin)                                                                       Nucleus               Transcription regulator
  1.036         P36578   RPL4          Ribosomal protein L4                                                                                                         Cytoplasm             Enzyme
  1.033         P28066   PSMA5         Proteasome (prosome, macropain) subunit, alpha type, 5                                                                       Cytoplasm             Peptidase
  1.032         P08238   HSP90AB1      Heat shock protein 90 kDa alpha (cytosolic), class B member 1                                                                Cytoplasm             Enzyme
  1.03          P52907   CAPZA1        Capping protein (actin filament) muscle Z-line, alpha 1                                                                      Cytoplasm             Other
  1.03          P16152   CAR1          Carbonyl reductase 1                                                                                                         Cytoplasm             Enzyme
  1.028         Q14019   COTL1         Coactosin-like F-actin binding protein 1                                                                                     Cytoplasm             Other
  1.027         P04632   CAPNS1        Calpain, small subunit 1                                                                                                     Cytoplasm             Peptidase
  1.026         P19105   MYL12A        Myosin, light chain 12A, regulatory, nonsarcomeric                                                                           Cytoplasm             Other
  1.024         P12814   ACTN1         Actinin, alpha 1                                                                                                             Cytoplasm             Other
  1.021         P50395   GD12          GDP dissociation inhibitor 2                                                                                                 Cytoplasm             Other
  1.02          Q01518   CAP1          CAP, adenylate cyclase-associated protein 1 (yeast)                                                                          Plasma membrane       Other
  1.018         J3KPE3   GNB2L1        Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1                                                    Cytoplasm             Enzyme
  1.014         Q99880   HIST1H2BL     Histone cluster 1, H2bl                                                                                                      Nucleus               Other
  1.012         P27695   APEX1         APEX nuclease (multifunctional DNA repair enzyme) 1                                                                          Nucleus               Enzyme
  1.007         P68371   TUBB4B        Tubulin, beta 4B class IVb                                                                                                   Cytoplasm             Other
  1.006         F5GZS6   SLC3A2        Solute carrier family 3 (amino acid transporter heavy chain), member 2                                                       Plasma membrane       Transporter
  1.004         O15371   EIF3D         Eukaryotic translation initiation factor 3, subunit D                                                                        Cytoplasm             Other
  1.002         D6RG13   RPS3A         Ribosomal protein S3A                                                                                                        Nucleus               Other
  1.001         M0R2L9   RPS19         Ribosomal protein S19                                                                                                        Cytoplasm             Other

**Abbreviation:** PLB, plumbagin.

###### 

Proteins downregulated by PLB in SCC25 cells

  Fold change   ID           Symbol          Entrez gene name                                                                                         Location              Type(s)
  ------------- ------------ --------------- -------------------------------------------------------------------------------------------------------- --------------------- -------------------------
  −3.32         P52306       RAP1GDS1        RAP1, GTP-GDP dissociation stimulator 1                                                                  Cytoplasm             Other
  −2.964        P29966       MARCKS          Myristoylated alanine-rich protein kinase C substrate                                                    Plasma membrane       Other
  −2.937        P04264       KRT1            Keratin 1                                                                                                Cytoplasm             Other
  −2.79         Q15942       ZYX             Zyxin                                                                                                    Plasma membrane       Other
  −2.644        P35527       KRT9            Keratin 9                                                                                                Other                 Other
  −2.642        P80723       BASP1           Brain abundant, membrane attached signal protein 1                                                       Nucleus               Transcription regulator
  −2.561        B8ZZQ6       PTMA            Prothymosin, alpha                                                                                       Nucleus               Other
  −2.542        P25786       PSMA1           Proteasome (prosome, macropain) subunit, alpha type, 1                                                   Cytoplasm             Peptidase
  −2.476        P35637       FUS             FUS RNA binding protein                                                                                  Nucleus               Transcription regulator
  −2.439        P16989       YBX3            Y box binding protein 3                                                                                  Nucleus               Transcription regulator
  −2.394        K7EL20       EIF3G           Eukaryotic translation initiation factor 3, subunit G                                                    Cytoplasm             Other
  −2.346        P13726       F3              Coagulation factor III (thromboplastin, tissue factor)                                                   Plasma membrane       Transmembrane receptor
  −2.3          Q08J23       NSUN2           NOP2/Sun RNA methyltransferase family, member 2                                                          Nucleus               Enzyme
  −2.244        P47895       ALDH1A3         Aldehyde dehydrogenase 1 family, member A3                                                               Cytoplasm             Enzyme
  −2.128        P26358       DNMT1           DNA (cytosine-5-)-methyltransferase 1                                                                    Nucleus               Enzyme
  −2.111        Q15582       TGFBI           Transforming growth factor, beta-induced, 68 kDa                                                         Extracellular space   Other
  −2.081        P30153       PPP2R1A         Protein phosphatase 2, regulatory subunit A, alpha                                                       Cytoplasm             Phosphatase
  −2.052        P06744       GPI             Glucose-6-phosphate isomerase                                                                            Extracellular space   Enzyme
  −2.018        Q5JXT2       NOP56           NOP56 ribonucleoprotein                                                                                  Nucleus               Other
  −2.013        P53621       COPA            Coatomer protein complex, subunit alpha                                                                  Cytoplasm             Transporter
  −1.946        Q16777       HIST2H2AC       Histone cluster 2, H2ac                                                                                  Nucleus               Other
  −1.921        C9JNR4       RHOA            Ras family member A                                                                                      Cytoplasm             Enzyme
  −1.921        F8VWS0       RPLP0           Ribosomal protein, large, P0                                                                             Cytoplasm             Other
  −1.915        P09211       GSTP1           Glutathione *S*-transferase pi 1                                                                         Cytoplasm             Enzyme
  −1.88         Q06830       PRDX1           Peroxiredoxin 1                                                                                          Cytoplasm             Enzyme
  −1.87         P11498       PC              Pyruvate carboxylase                                                                                     Cytoplasm             Enzyme
  −1.86         P33176       KIF5B           Kinesin family member 5B                                                                                 Cytoplasm             Other
  −1.858        I7HJJ0       SLC25A6         Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6              Cytoplasm             Transporter
  −1.856        P52566       ARHGDIB         Rho GDP dissociation inhibitor (GDI) beta                                                                Cytoplasm             Other
  −1.844        P67809       YBX1            Y box binding protein 1                                                                                  Nucleus               Transcription regulator
  −1.764        Q9UKY7       CDV3            CDV3 homolog (mouse)                                                                                     Cytoplasm             Other
  −1.764        B7Z972       PCMT1           Protein-[l]{.smallcaps}-isoaspartate ([d]{.smallcaps}-aspartate) *O*-methyltransferase                   Cytoplasm             Enzyme
  −1.737        E9PBS1       PAICS           Phosphoribosylaminoimidazole carboxylase, phosphoribo-sylaminoimidazole succinocarboxamide synthetase    Cytoplasm             Enzyme
  −1.727        P13010       XRCC5           X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)   Nucleus               Enzyme
  −1.723        P26368       U2AF2           U2 small nuclear RNA auxiliary factor 2                                                                  Nucleus               Other
  −1.722        P28074       PSMB5           Proteasome (prosome, macropain) subunit, beta type, 5                                                    Cytoplasm             Peptidase
  −1.715        P15374       UCHL3           Ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)                                        Cytoplasm             Peptidase
  −1.709        P68104       EEF1A1          Eukaryotic translation elongation factor 1 alpha 1                                                       Cytoplasm             Translation regulator
  −1.698        J3KTF8       ARHGDIA         Rho GDP dissociation inhibitor (GDI) alpha                                                               Cytoplasm             Other
  −1.694        O75367       H2AFY           H2A histone family, member Y                                                                             Nucleus               Other
  −1.663        P63010       AP2B1           Adaptor-related protein complex 2, beta 1 subunit                                                        Plasma membrane       Transporter
  −1.655        B4DUR8       CCT3            Chaperonin containing TCP1, subunit 3 (gamma)                                                            Cytoplasm             Other
  −1.646        P13667       PDIA4           Protein disulfide isomerase family A, member 4                                                           Cytoplasm             Enzyme
  −1.638        P23229       ITGA6           Integrin, alpha 6                                                                                        Plasma membrane       Transmembrane receptor
  −1.632        F8VZ29       UBE2N           Ubiquitin-conjugating enzyme E2N                                                                         Cytoplasm             Enzyme
  −1.631        Q9UHI5       SLC7A8          Solute carrier family 7 (amino acid transporter light chain, L system), member 8                         Plasma membrane       Transporter
  −1.629        F8W726       UBAP2L          Ubiquitin associated protein 2-like                                                                      Other                 Other
  −1.617        Q9HB71       CACYBP          Calcyclin binding protein                                                                                Nucleus               Other
  −1.614        Q12905       ILF2            Interleukin enhancer binding factor 2                                                                    Nucleus               Transcription regulator
  −1.599        O43390       HNRNPR          Heterogeneous nuclear ribonucleoprotein R                                                                Nucleus               Other
  −1.599        E9PK47       PYGL            Phosphorylase, glycogen, liver                                                                           Cytoplasm             Enzyme
  −1.579        Q6NYC8       PPP1R18         Protein phosphatase 1, regulatory subunit 18                                                             Other                 Other
  −1.574        O60884       DNAJA2          DNAJ (Hsp40) homolog, subfamily A, member 2                                                              Nucleus               Enzyme
  −1.566        E9PDF6       MYO1B           Myosin IB                                                                                                Cytoplasm             Other
  −1.565        Q02878       RPL6            Ribosomal protein L6                                                                                     Cytoplasm             Other
  −1.562        P05386       RPLP1           Ribosomal protein, large, P1                                                                             Cytoplasm             Other
  −1.56         E9PLD0       RAB1B           RAB1B, member RAS oncogene family                                                                        Cytoplasm             Other
  −1.556        Q14247       CTTN            Cortactin                                                                                                Plasma membrane       Other
  −1.554        P42704       LRPPRC          Leucine-rich pentatricopeptide repeat containing                                                         Cytoplasm             Other
  −1.549        Q9H4M9       EHD1            EH-domain containing 1                                                                                   Cytoplasm             Other
  −1.498        P30084       ECHS1           Enoyl CoA hydratase, short chain, 1, mitochondrial                                                       Cytoplasm             Enzyme
  −1.498        P49915       GMPS            Guanine monphosphate synthase                                                                            Nucleus               Enzyme
  −1.496        Q86VP6       CAND1           Cullin-associated and neddylation-dissociated 1                                                          Cytoplasm             Transcription regulator
  −1.49         P49588       AARS            Alanyl-tRNA synthetase                                                                                   Cytoplasm             Enzyme
  −1.482        P62314       SNRPD1          Small nuclear ribonucleoprotein D1 polypeptide 16 kDa                                                    Nucleus               Other
  −1.474        P20290       BTF3            Basic transcription factor 3                                                                             Nucleus               Transcription regulator
  −1.473        Q9ULV4       CORO1C          Coronin, actin binding protein, 1C                                                                       Cytoplasm             Other
  −1.468        P51858       HDGF            Hepatoma-derived growth factor                                                                           Extracellular space   Growth factor
  −1.468        G3V1A1       RPL8            Ribosomal protein L8                                                                                     Other                 Other
  −1.466        Q9UHD8       SEPT9           Septin 9                                                                                                 Cytoplasm             Enzyme
  −1.461        P55060       CSE1L           CSE1 chromosome segregation 1-like (yeast)                                                               Nucleus               Transporter
  −1.46         P61978       HNRNPK          Heterogeneous nuclear ribonucleoprotein K                                                                Nucleus               Other
  −1.457        P84077       ARF1            ADP-ribosylation factor 1                                                                                Cytoplasm             Enzyme
  −1.452        P62081       RPS7            Ribosomal protein S7                                                                                     Cytoplasm             Other
  −1.447        K7EJ57       TOMM40          Translocase of outer mitochondrial membrane 40 homolog (yeast)                                           Cytoplasm             Ion channel
  −1.443        Q9Y5B9       SUPT16H         Suppressor of Ty 16 homolog (*S. cerevisiae*)                                                            Nucleus               Transcription regulator
  −1.434        P49327       FASN            Fatty acid synthase                                                                                      Cytoplasm             Enzyme
  −1.432        P30086       PEBP1           Phosphatidylethanolamine binding protein 1                                                               Cytoplasm             Other
  −1.421        C9J9K3       RPSA            Ribosomal protein SA                                                                                     Cytoplasm             Translation regulator
  −1.421        Q12874       SF3A3           Splicing factor 3a, subunit 3, 60 kDa                                                                    Nucleus               Other
  −1.42         P43490       NAMPT           Nicotinamide phosphoribosyltransferase                                                                   Extracellular space   Cytokine
  −1.41         Q14444       CAPRIN1         Cell cycle associated protein 1                                                                          Plasma membrane       Other
  −1.409        P13928       ANXA8/ANXA8L1   Annexin A8-like 1                                                                                        Plasma membrane       Other
  −1.408        Q9UK76       HN1             Hematological and neurological expressed 1                                                               Nucleus               Other
  −1.404        P00367       GLUD1           Glutamate dehydrogenase 1                                                                                Cytoplasm             Enzyme
  −1.402        Q14764       MVP             Major vault protein                                                                                      Nucleus               Other
  −1.391        Q9NTK5       OLA1            Obg-like ATPase 1                                                                                        Cytoplasm             Other
  −1.391        P08670       VIM             Vimentin                                                                                                 Cytoplasm             Other
  −1.387        P07195       LDHB            Lactate dehydrogenase B                                                                                  Cytoplasm             Enzyme
  −1.384        P07384       CAPN1           Calpain 1, (mu/I) large subunit                                                                          Cytoplasm             Peptidase
  −1.378        Q5T7C4       HMGB1           High mobility group box 1                                                                                Nucleus               Transcription regulator
  −1.374        P55884       EIF3B           Eukaryotic translation initiation factor 3, subunit B                                                    Cytoplasm             Translation regulator
  −1.367        Q15417       CNN3            Calponin 3, acidic                                                                                       Cytoplasm             Other
  −1.367        Q96AE4       FUBP1           Far upstream element (FUSE) binding protein 1                                                            Nucleus               Transcription regulator
  −1.366        F8W1N5       NACA            Nascent polypeptide-associated complex alpha subunit                                                     Cytoplasm             Transcription regulator
  −1.364        Q32Q12       NME1-NME2       NME1-NME2 readthrough                                                                                    Cytoplasm             Other
  −1.361        P21796       VDAC1           Voltage-dependent anion channel 1                                                                        Cytoplasm             Ion channel
  −1.359        P54136       RARS            Arginyl-tRNA synthetase                                                                                  Cytoplasm             Enzyme
  −1.359        Q9H2G2       SLK             STE20-like kinase                                                                                        Nucleus               Kinase
  −1.359        Q12792       TWF1            Twinfilin actin-binding protein 1                                                                        Cytoplasm             Kinase
  −1.354        Q7KZF4       SND1            Staphylococcal nuclease and tudor domain containing 1                                                    Nucleus               Enzyme
  −1.347        P20042       EIF2S2          Eukaryotic translation initiation factor 2, subunit 2 beta, 38 kDa                                       Cytoplasm             Translation regulator
  −1.344        Q14204       DYNC1H1         Dynein, cytoplasmic 1, heavy chain 1                                                                     Cytoplasm             Peptidase
  −1.34         K7EIP4       LAMA3           Laminin, alpha 3                                                                                         Extracellular space   Other
  −1.337        P24534       EEF1B2          Eukaryotic translation elongation factor 1 beta 2                                                        Cytoplasm             Translation regulator
  −1.331        P61353       RPL27           Ribosomal protein L27                                                                                    Cytoplasm             Other
  −1.33         P41250       GARS            Glycyl-tRNA synthetase                                                                                   Cytoplasm             Enzyme
  −1.326        P04080       CSTB            Cystatin B (stefin B)                                                                                    Cytoplasm             Peptidase
  −1.326        G8JLD5       DNM1L           Dynamin 1-like                                                                                           Cytoplasm             Enzyme
  −1.317        P04792       HSPB1           Heat shock 27 kDa protein 1                                                                              Cytoplasm             Other
  −1.315        P12956       XRCC6           X-ray repair complementing defective repair in Chinese hamster cells 6                                   Nucleus               Enzyme
  −1.308        P0CW22       RPS17           Ribosomal protein S17                                                                                    Cytoplasm             Other
  −1.306        Q13283       G3BP1           GTPase activating protein (SH3 domain) binding protein 1                                                 Nucleus               Enzyme
  −1.306        Q15181       PPA1            Pyrophosphatase (inorganic) 1                                                                            Cytoplasm             Enzyme
  −1.302        P14618       PKM             Pyruvate kinase, muscle                                                                                  Cytoplasm             Kinase
  −1.297        P27797       CALR            Calreticulin                                                                                             Cytoplasm             Transcription regulator
  −1.287        P48643       CCT5            Chaperonin containing TCP1, subunit 5 (epsilon)                                                          Cytoplasm             Other
  −1.286        P61158       ACTR3           ARP3 actin-related protein 3 homolog (yeast)                                                             Plasma membrane       Other
  −1.286        Q07021       C1QBP           Complement component 1, q subcomponent binding protein                                                   Cytoplasm             Transcription regulator
  −1.283        P41091       EIF2S3          Eukaryotic translation initiation factor 2, subunit 3 gamma, 52 kDa                                      Cytoplasm             Translation regulator
  −1.28         P26639       TARS            Threonyl-tRNA synthetase                                                                                 Nucleus               Enzyme
  −1.279        P43243       MATR3           Matrin 3                                                                                                 Nucleus               Other
  −1.278        B4DS13       EIF4B           Eukaryotic translation initiation factor 4B                                                              Cytoplasm             Translation regulator
  −1.277        P09914       IFIT1           Interferon-induced protein with tetratricopeptide repeats 1                                              Cytoplasm             Other
  −1.277        Q15084       PDIA6           Protein disulfide isomerase family A, member 6                                                           Cytoplasm             Enzyme
  −1.276        P52292       KPNA2           Karyopherin alpha 2 (RAG cohort 1, importin alpha 1)                                                     Nucleus               Transporter
  −1.271        P12004       PCNA            Proliferating cell nuclear antigen                                                                       Nucleus               Enzyme
  −1.269        P13639       EEF2            Eukaryotic translation elongation factor 2                                                               Cytoplasm             Translation regulator
  −1.267        F5H018       RAN             RAN, member RAS oncogene family                                                                          Nucleus               Enzyme
  −1.265        P40121       CAPG            Capping protein (actin filament), gelsolin-like                                                          Nucleus               Other
  −1.264        E7EQR4       EZR             Ezrin                                                                                                    Plasma membrane       Other
  −1.264        P43686       PSMC4           Proteasome (prosome, macropain) 26S subunit, ATPase, 4                                                   Nucleus               Peptidase
  −1.263        P63241       EIF5A           Eukaryotic translation initiation factor 5A                                                              Cytoplasm             Translation regulator
  −1.261        B1AK85       CAPZB           Capping protein (actin filament) muscle Z-line, beta                                                     Cytoplasm             Other
  −1.254        Q14974       KPNB1           Karyopherin (importin) beta 1                                                                            Nucleus               Transporter
  −1.253        P07237       P4HB            Prolyl 4-hydroxylase, beta polypeptide                                                                   Cytoplasm             Enzyme
  −1.251        B4DLR8       NQO1            NAD(P)H dehydrogenase, quinone 1                                                                         Cytoplasm             Enzyme
  −1.251        O60664       PLIN3           Perilipin 3                                                                                              Cytoplasm             Other
  −1.251        P54725       RAD23A          RAD23 homolog A (*S. cerevisiae*)                                                                        Nucleus               Other
  −1.25         P18669       PGAM1           Phosphoglycerate mutase 1 (brain)                                                                        Cytoplasm             Phosphatase
  −1.248        P05141       SLC25A5         Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5              Cytoplasm             Transporter
  −1.247        P55263       ADK             Adenosine kinase                                                                                         Nucleus               Kinase
  −1.245        P49321       NASP            Nuclear autoantigenic sperm protein (histone-binding)                                                    Nucleus               Other
  −1.244        P22626       HNRNPA2B1       Heterogeneous nuclear ribonucleoprotein A2/B1                                                            Nucleus               Other
  −1.243        P01892       HLA-A           Major histocompatibility complex, class I, A                                                             Plasma membrane       Other
  −1.242        P54727       RAD23B          RAD23 homolog B (*S. cerevisiae*)                                                                        Nucleus               Other
  −1.239        P07737       PFN1            Profilin 1                                                                                               Cytoplasm             Other
  −1.237        P21333       FLNA            Filamin A, alpha                                                                                         Cytoplasm             Other
  −1.236        P06733       ENO1            Enolase 1, (alpha)                                                                                       Cytoplasm             Enzyme
  −1.234        P09382       LGALS1          Lectin, galactoside-binding, soluble, 1                                                                  Extracellular space   Other
  −1.232        P35998       PSMC2           Proteasome (prosome, macropain) 26S subunit, ATPase, 2                                                   Nucleus               Peptidase
  −1.23         P52272       HNRNPM          Heterogeneous nuclear ribonucleoprotein M                                                                Nucleus               Other
  −1.229        P06396       GSN             Gelsolin                                                                                                 Extracellular space   Other
  −1.229        Q99714       HSD17B10        Hydroxysteroid (17-beta) dehydrogenase 10                                                                Cytoplasm             Enzyme
  −1.227        P30044       PRDX5           Peroxiredoxin 5                                                                                          Cytoplasm             Enzyme
  −1.224        P00491       PNP             Purine nucleoside phosphorylase                                                                          Nucleus               Enzyme
  −1.223        P39023       RPL3            Ribosomal protein L3                                                                                     Cytoplasm             Other
  −1.221        P37802       TAGLN2          Transgelin 2                                                                                             Cytoplasm             Other
  −1.22         Q7L2H7       EIF3M           Eukaryotic translation initiation factor 3, subunit M                                                    Other                 Other
  −1.22         P62906       RPL10A          Ribosomal protein L10a                                                                                   Nucleus               Other
  −1.219        P62937       PPIA            Peptidylprolyl isomerase A (cyclophilin A)                                                               Cytoplasm             Enzyme
  −1.215        P11766       ADH5            Alcohol dehydrogenase 5 (class III), chi polypeptide                                                     Cytoplasm             Enzyme
  −1.213        Q09666       AHNAK           AHNAK nucleoprotein                                                                                      Nucleus               Other
  −1.207        E7ETK0       RPS24           Ribosomal protein S24                                                                                    Cytoplasm             Other
  −1.205        Q03135       CAV1            Caveolin 1, caveolae protein, 22 kDa                                                                     Plasma membrane       Transmembrane receptor
  −1.203        P35606       COPB2           Coatomer protein complex, subunit beta 2 (beta prime)                                                    Cytoplasm             Transporter
  −1.203        P52209       PGD             Phosphogluconate dehydrogenase                                                                           Cytoplasm             Enzyme
  −1.203        Q13200       PSMD2           Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2                                               Cytoplasm             Other
  −1.198        P60842       EIF4A1          Eukaryotic translation initiation factor 4A1                                                             Cytoplasm             Translation regulator
  −1.198        P18124       RPL7            Ribosomal protein L7                                                                                     Nucleus               Transcription regulator
  −1.193        P05161       ISG15           ISG15 ubiquitin-like modifier                                                                            Extracellular space   Other
  −1.184        A0A075B730   EPPK1           Epiplakin 1                                                                                              Cytoplasm             Other
  −1.184        Q02790       FKBP4           FK506 binding protein 4, 59 kDa                                                                          Nucleus               Enzyme
  −1.184        M0R0F0       RPS5            Ribosomal protein S5                                                                                     Cytoplasm             Other
  −1.183        P35221       CTNNA1          Catenin (cadherin-associated protein), alpha 1, 102 kDa                                                  Plasma membrane       Other
  −1.179        Q01105       SET             SET nuclear proto-oncogene                                                                               Nucleus               Phosphatase
  −1.175        P05387       RPLP2           Ribosomal protein, large, P2                                                                             Cytoplasm             Other
  −1.174        Q00839       HNRNPU          Heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)                                 Nucleus               Transporter
  −1.173        O15143       ARPC1B          Actin related protein 2/3 complex, subunit 1B, 41 kDa                                                    Cytoplasm             Other
  −1.173        P23528       CFL1            Cofilin 1 (non-muscle)                                                                                   Nucleus               Other
  −1.173        A2A2Y8       COL17A1         Collagen, type XVII, alpha 1                                                                             Extracellular space   Other
  −1.171        E7EQV3       PABPC1          Poly(A) binding protein, cytoplasmic 1                                                                   Cytoplasm             Translation regulator
  −1.171        F8W7C6       RPL10           Ribosomal protein L10                                                                                    Cytoplasm             Other
  −1.158        Q14980       NUMA1           Nuclear mitotic apparatus protein 1                                                                      Nucleus               Other
  −1.157        P27824       CANX            Calnexin                                                                                                 Cytoplasm             Other
  −1.155        Q14134       TRIM29          Tripartite motif containing 29                                                                           Cytoplasm             Transcription regulator
  −1.154        E9PCY7       HNRNPH1         Heterogeneous nuclear ribonucleoprotein H1 (H)                                                           Nucleus               Other
  −1.153        O00299       CLIC1           Chloride intracellular channel 1                                                                         Nucleus               Ion channel
  −1.145        Q13813       SPTAN1          Spectrin, alpha, nonerythrocytic 1                                                                       Plasma membrane       Other
  −1.144        P07900       HSP90AA1        Heat shock protein 90 kDa alpha (cytosolic), class A member 1                                            Cytoplasm             Enzyme
  −1.143        P68363       TUBA1B          Tubulin, alpha 1b                                                                                        Cytoplasm             Other
  −1.14         Q5JP53       TUBB            Tubulin, beta class I                                                                                    Cytoplasm             Other
  −1.137        P60174       TPI1            Triosephosphate isomerase 1                                                                              Cytoplasm             Enzyme
  −1.136        P27482       CALML3          Calmodulin-like 3                                                                                        Cytoplasm             Other
  −1.135        P19338       NCL             Nucleolin                                                                                                Nucleus               Other
  −1.124        P18206       VCL             Vinculin                                                                                                 Plasma membrane       Enzyme
  −1.117        P10809       HSPD1           Heat shock 60 kDa protein 1 (chaperonin)                                                                 Cytoplasm             Enzyme
  −1.117        Q92598       HSPH1           Heat shock 105 kDa/110 kDa protein 1                                                                     Cytoplasm             Other
  −1.114        K7ELL7       PRKCSH          Protein kinase C substrate 80K-H                                                                         Cytoplasm             Enzyme
  −1.112        P05198       EIF2S1          Eukaryotic translation initiation factor 2, subunit 1 alpha, 35 kDa                                      Cytoplasm             Translation regulator
  −1.111        P30050       RPL12           Ribosomal protein L12                                                                                    Nucleus               Other
  −1.108        F8W6I7       HNRNPA1         Heterogeneous nuclear ribonucleoprotein A1                                                               Nucleus               Other
  −1.108        P00338       LDHA            Lactate dehydrogenase A                                                                                  Cytoplasm             Enzyme
  −1.106        Q16658       FSCN1           Fascin actin-bundling protein 1                                                                          Cytoplasm             Other
  −1.103        P78371       CCT2            Chaperonin containing TCP1, subunit 2 (beta)                                                             Cytoplasm             Kinase
  −1.102        P68133       ACTA1           Actin, alpha 1, skeletal muscle                                                                          Cytoplasm             Other
  −1.095        P29728       OAS2            2′--5′-oligoadenylate synthetase 2, 69/71 kDa                                                            Cytoplasm             Enzyme
  −1.092        P13797       PLS3            Plastin 3                                                                                                Cytoplasm             Other
  −1.09         D6RFM5       SDHA            Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)                                            Cytoplasm             Enzyme
  −1.082        B4E022       TKT             Transketolase                                                                                            Cytoplasm             Enzyme
  −1.081        O95433       AHSA1           AHA1, activator of heat shock 90 kDa protein ATPase homologue 1 (yeast)                                  Cytoplasm             Other
  −1.077        E7EX73       EIF4G1          Eukaryotic translation initiation factor 4 gamma, 1                                                      Cytoplasm             Translation regulator
  −1.076        P04406       GAPDH           Glyceraldehyde-3-phosphate dehydrogenase                                                                 Cytoplasm             Enzyme
  −1.076        P26599       PTBP1           Polypyrimidine tract binding protein 1                                                                   Nucleus               Enzyme
  −1.076        P11216       PYGB            Phosphorylase, glycogen; brain                                                                           Cytoplasm             Enzyme
  −1.072        Q13838       DDX39B          DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B                                                               Nucleus               Enzyme
  −1.072        Q99733       NAP1L4          Nucleosome assembly protein 1-like 4                                                                     Cytoplasm             Other
  −1.068        P29692       EEF1D           Eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)                   Cytoplasm             Translation regulator
  −1.067        O00151       PDLIM1          PDZ and LIM domain 1                                                                                     Cytoplasm             Transcription regulator
  −1.065        O75369       FLNB            Filamin B, beta                                                                                          Cytoplasm             Other
  −1.063        P62191       PSMC1           Proteasome (prosome, macropain) 26S subunit, ATPase, 1                                                   Nucleus               Peptidase
  −1.059        P00558       PGK1            Phosphoglycerate kinase 1                                                                                Cytoplasm             Kinase
  −1.055        P50990       CCT8            Chaperonin containing TCP1, subunit 8 (theta)                                                            Cytoplasm             Enzyme
  −1.052        F5H7V9       TNC             Tenascin C                                                                                               Extracellular space   Other
  −1.049        Q99613       EIF3C           Eukaryotic translation initiation factor 3, subunit C                                                    Other                 Translation regulator
  −1.048        P45880       VDAC2           Voltage-dependent anion channel 2                                                                        Cytoplasm             Ion channel
  −1.043        P26641       EEF1G           Eukaryotic translation elongation factor 1 gamma                                                         Cytoplasm             Translation regulator
  −1.043        P00441       SOD1            Superoxide dismutase 1, soluble                                                                          Cytoplasm             Enzyme
  −1.039        E9PFD7       EGFR            Epidermal growth factor receptor                                                                         Plasma membrane       Kinase
  −1.039        Q9NQC3       RTN4            Reticulon 4                                                                                              Cytoplasm             Other
  −1.037        Q9NUQ9       FAM49B          Family with sequence similarity 49, member B                                                             Extracellular space   Other
  −1.037        P08729       KRT7            Keratin 7                                                                                                Cytoplasm             Other
  −1.037        P25398       RPS12           Ribosomal protein S12                                                                                    Cytoplasm             Other
  −1.034        Q13347       EIF3I           Eukaryotic translation initiation factor 3, subunit I                                                    Cytoplasm             Translation regulator
  −1.034        F8VQE1       TRMT1           tRNA methyltransferase 1 homolog (*S. cerevisiae*)                                                       Extracellular space   Enzyme
  −1.031        P63261       ACTG1           Actin, gamma 1                                                                                           Cytoplasm             Other
  −1.027        O43707       ACTN4           Actinin, alpha 4                                                                                         Cytoplasm             Other
  −1.027        P13796       LCP1            Lymphocyte cytosolic protein 1 (L-plastin)                                                               Cytoplasm             Other
  −1.027        E7EUY0       PRKDC           Protein kinase, DNA-activated, catalytic polypeptide                                                     Nucleus               Kinase
  −1.025        Q8NC51       SERBP1          SERPINE1 mRNA binding protein 1                                                                          Cytoplasm             Other
  −1.025        Q13263       TRIM28          Tripartite motif containing 28                                                                           Nucleus               Transcription regulator
  −1.023        Q00610       CLTC            Clathrin, heavy chain (Hc)                                                                               Plasma membrane       Other
  −1.022        P40227       CCT6A           Chaperonin containing TCP1, subunit 6A (zeta 1)                                                          Cytoplasm             Other
  −1.021        P63104       YWHAZ           Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta                             Cytoplasm             Enzyme
  −1.02         P51149       RAB7A           RAB7A, member RAS oncogene family                                                                        Cytoplasm             Enzyme
  −1.018        P25787       PSMA2           Proteasome (prosome, macropain) subunit, alpha type, 2                                                   Cytoplasm             Peptidase
  −1.016        P35268       RPL22           Ribosomal protein L22                                                                                    Nucleus               Other
  −1.012        Q04828       AKR1C1/AKR1C2   Aldo-keto reductase family 1, member C2                                                                  Cytoplasm             Enzyme
  −1.01         P08758       ANXA5           Annexin A5                                                                                               Plasma membrane       Other
  −1.01         Q5VU59       TPM3            Tropomyosin 3                                                                                            Cytoplasm             Other
  −1.009        Q15233       NONO            Non-POU domain containing, octamer-binding                                                               Nucleus               Other
  −1.009        P62258       YWHAE           Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon                          Cytoplasm             Other
  −1.008        P35579       MYH9            Myosin, heavy chain 9, nonmuscle                                                                         Cytoplasm             Enzyme
  −1.005        P16144       ITGB4           Integrin, beta 4                                                                                         Plasma membrane       Transmembrane receptor
  −1.001        Q15149       PLEC            Plectin                                                                                                  Cytoplasm             Other

**Abbreviation:** PLB, plumbagin.

###### 

Potential signaling pathways regulated by PLB in SCC25 cells

  Ingenuity canonical pathways                                      −logP      Protein molecules
  ----------------------------------------------------------------- ---------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  EIF2 signaling                                                    3.31E01    EIF2S1, EIF2S2, EIF2S3, EIF3B, EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3I, EIF3M, EIF4A1, EIF4G1, PABPC1, PPP1CA, RPL3, RPL4, RPL5, RPL6, RPL7, RPL8, RPL9, RPL10, RPL12, RPL22, RPL27, RPL10A, RPLP0, RPLP1, RPLP1, RPLP2, RPS5, RPS7, RPS8, RPS12, RPS14, RPS15, RPS17, RPS19, RPS24, RPS27A, RPS3A, RPS4X, RPSA
  Regulation of eIF4 and p70S6k signaling                           2.03E01    EIF2S1, EIF2S2, EIF2S3, EIF3B, EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3I, EIF3M, EIF4A1, EIF4G1, ITGB1, PABPC1, PPP2R1A, RPS5, RPS7, RPS8, RPS12, RPS14, RPS15, RPS17, RPS19, RPS24, RPS27A, RPS3A, RPS4X, RPSA
  Remodeling of epithelial adherens junctions                       1.52E01    ACTA1, ACTG1, ACTN1, ACTN4, ACTR3, ARPC1B, CTNNA1, CTNND1, DNM1L, IQGAP1, RAB7A, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B, VCL, ZYX
  mTOR signaling                                                    1.43E01    EIF3B, EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3I, EIF3M, EIF4A1, EIF4B, EIF4G1, PPPAR1A, RHOA, RPS5, RPS7, RPS8, RPS12, RPS14, RPS15, RPS17, RPS19, RPS24, RPS27A, RPS3A, RPS4X, RPSA
  Protein ubiquitination pathway                                    1.36E01    HLA-A, HSP90AA1, HSP90AB1, HSP90B1, HSPA4, HSPA5, HSPA8, HSPA9, HSPB1, HSPD1, HSPH1, PSMA1, PSMA2, PSMA4, PSMA5, PSMB1, PSMB5, PSMC1, PSMC2, PSMC3, PSMC4, PSMD1, PSMD2, PSME2, UBA1, UBE2N, UCHL1, UCHL3, USP5
  Nrf2-mediated oxidative stress response                           5.42E00    ACTA1, ACTG1, CBR1, DNAJA2, GSTP1, NQO1, HSP90AA1, PPIB, PRDX1, SOD1, STIP1, VCP
  Epithelial adherens junction signaling                            5.21E00    ACTA1, ACTG1, ACTN1, ACTN4, ACTR3, ARPC1B, CTNNA1, CTNND1, EGFR, IQGAP1, JUP, MYH9, RHO1, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B, VAL, ZYX
  Caveolar-mediated endocytosis signaling                           5.18E00    ACTA1, ACTG1, CAV1, COPA, COPB2, COPE, EGFR, FLNA, FLNB, HLA-A, ITGA6, ITGB1, ITGB4, PTRF
  RhoA signaling                                                    5.10E00    ACTA1, ACTG1, ACTR3, ARPC1B, CFL1, EZR, KTN1, MAN, MYL12A, PFN1, RHOA, SEPT9
  Oxidative phosphorylation                                         5.08E00    UQCRH, ATP5D, ATP5L, UQCRB, MT-CO2, ATP5H, NDUFA5, NDUFAB1, NDUFB6, ATP5F1, COX4I1, SDHA, ATP5J, COX7A2, COX6B1, COX17, ATP5O, ATP5A1, NDUFS3, ATP5C1, MT-ND1, NDUFB11, ATP5B, NDUFS8, UQCR10, CYC1, UQCRC2, COX5A, CYCS, UQCRC1, COX5B
  TCA cycle II (eukaryotic)                                         4.85E00    SDHA, SUCLA2, CS, SUCLG1, DLST, ACO2, DLD, IDH3A, OGDH, MDH2, FH, MDH1, IDH3B
  Germ cell--Sertoli cell junction signaling                        4.76E00    ACTA1, ACTG1, ACTN1, ACTN4, CFL1, CTNNA1, CTNND1, GSN, IQGAP1, ITGA6, ITGB1, JUP, PAK2, PAC2, RHOA, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B, ZYX
  Actin nucleation by ARP-WASP complex                              4.64E00    RHOA, ARPC3
  Aspartate degradation II                                          4.11E00    GOT2
  Superpathway of methionine degradation                            4.08E00    GOT2
  Tight junction signaling                                          4.08E00    MYL6, PPP2CA, HSF1, ACTA2, VAPA, PRKAR2A, RAC1, YBX3, CDC42, ACTG1, CPSF6, PPP2R1A, CLDN4, MYH9, SAFB, VCL, SPTAN1, CTNNA1, CSTF3, VASP, RHOA
  2-Ketoglutarate dehydrogenase complex                             3.89E00    DLST, DLD, OGDH
  Integrin signaling                                                3.87E00    ACTA1, ACTG1, ACTN1, ACTN4, ACTR3, ARF1, ARPC1B, CAPN1, CAPN2, CAPNS1, CAV1, CTTN, ITGA6, ITGB1, ITGB4, MYL12A, PAK2, RAC2, RHOA, VCL, ZYX
  Clathrin-mediated endocytosis signaling                           3.80E00    ACTA1, ACTG1, ACTR3, AP2B1, ARPC1B, CLTC, CTTN, DNM1L, HSPA8, ITGB1, ITGB4, RAB7A, TFRC
  Cell cycle: G~2~/M DNA damage checkpoint regulation               3.78E00    YWHAQ, PRKDC, YWHAG, YWHAE, YWHAH, YWHAB, YWHAZ, SFN, SKP1, CDK1
  Glycolysis I                                                      3.75E00    ALDOA, ALD0C, ENO1, GAPDH, GPI, PGAM1, PGAM1, PKG1, PKM, TPI1
  Ephrin receptor signaling                                         3.73E00    RHOA, AKT2, ARPC3, RAC2, ACTR3, MAPK1
  Unfolded protein response                                         3.66E00    CALR, CANX, DNAJA2, HSP90B1, HSPA4, HSPA5, HSPA8, HSPA9, HSPH1, P4HB, VCP
  Actin cytoskeleton signaling                                      3.64E00    ACTA1, ACTG1, ACTN1, ACTN4, ACTR3, ARPC1B, CFL1, FLNA, GSN, IQGAP1, ITGB1, MSN, MYH9, MYL12A, PAK2, PFN1, RAC2, RHOA, VCL
  Semaphorin signaling in neurons                                   3.47E00    RHOA, DPYSL2, PAK2, CFL2, MAPK1, CFL1, RHOC, RAC1
  Gluconeogenesis I                                                 3.46E00    ALDOA, ALDOC, ENO1, GAPDH, GPI, MDH2, PGAM1, PGK1
  Virus entry via endocytic pathways                                3.32E00    ACTA1, ACTG1, AP2B1 CAV1, CLTC, FLNA, FLNB, HLA-A, ITGA6, ITGB1, ITGB4, RAC2, TFRC
  Regulation of actin-based motility by rho                         3.31E00    ACTA1, ACTR3, ARHGDIA, ARPC1B, CFL1, GSN, ITGB1, MYL12A, PAK2, PFN1, RAC2, RHOA
  Mechanisms of viral exit from host cells                          3.27E00    CHMP4B, ACTA2, XPO1, LMNB2, PDCD6IP, ACTG1, LMNB1
  14-3-3-Mediated signaling                                         2.95E00    PDIA3, SFN, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B, VIM, YWHAB, YWHAE, YWHAG, YWHAQ, YWHAZ
  Superoxide radicals degradation                                   2.87E00    SOD1, SOD2, NQO1
  Spliceosomal cycle                                                2.86E00    U2AF2, U2AF1
  ILK signaling                                                     2.84E00    ACTA1, ACTG1, ACTN1, ACTN4, CDL1, DSP, FLNA, FLNB, ITGB1, ITGB4, KRT18, MYH9, NACA, PPP2R1A, RHOA, VIM
  Aryl hydrocarbon receptor signaling                               2.76E00    NQO1, GSTP1, ALDH, HSP27
  Ethanol degradation II                                            2.75E00    ADH5, HSD17B10, AKR1A1, ACSL3, DHRS9, ALDH1A3, ALDH3A2, ALDH9A1
  Noradrenaline and adrenaline degradation                          2.74E00    ADH5, HSD17B10, AKR1A1, DHRS9, ALDH1A3, ALDH3A2, ALDH9A1
  Glycogen degradation III                                          2.72E00    PGM3, PGM1, PYGB, PYGL
  Palmitate biosynthesis I (animals)                                2.71E00    FASN
  Granzyme B signaling                                              2.64E00    NUMA1, LMNB2, CYCS, LMNB1, PARP1
  Regulation of cellular mechanics by caplain protease              2.55E00    ACTN1, ACTN4, CAPN1, CAPN2, CAPNS1, EGFR, EZR, ITGB1, VCL
  Pentose phosphate pathway                                         2.51E00    PGD, TKT, PGLS, TALDO1
  BER pathway                                                       2.44E00    PCNA, PARP1, APEX1
  RhoGDI signaling                                                  2.43E00    ACTA1, ACTG1, ACTR3, ARHGDIA, ARHGDIB, ARPC1B, CFL1, EZR, GDI2, GNB2L1, ITGB1, MSN, MYL12A, PAK2, RHOA
  IGF-1 signaling                                                   2.42E00    SFN, STAT3
  Erk/MAPK signaling                                                2.41E00    RAP1B, ITGB1, PPP1CC, PXN, YWHAG, PAK2, YWHAH, MAPK1, YWHAB, PPP2CA, RRAS, ITGA2, YWHAZ, RAC1, PRKAR2A, TLN1, PPP1R14B, YWHAQ, PPP2R1A, HSPB1, PRKAR1A
  Adenine and adenosine salvage I                                   2.39E00    PNP
  Purine nucleotides de novo biosynthesis II                        2.36E00    ATIC, GART, GMPS, IMPDH2, PAICS
  Hypoxia signaling in the cardiovascular system                    2.34E00    HSP90AA1, HSP90AB1, HSP90B1, LDHA, NQO1, P4HB, UBE2N
  Glycogen degradation II                                           2.31E00    PGM3, PGM1, PYGB, PYGL
  Sertoli cell--Sertoli cell junction signaling                     2.26E00    ACTA1, ACTG1, ACTN1, ACTN4, CTNNA1, ITGB1, JUP, SPTAN1, SPTBN1, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B, YBX3
  Lipid antigen presentation by CD1                                 2.22E00    CALR, AP2A1, PDIA3, CANX
  Guanine and guanosine salvage I                                   2.18E00    PNP
  Myc mediated apoptosis signaling                                  2.17E00    FADD, SFN, YWHAB, YWHAE, YWHAG, YWHAQ, YWHAZ
  Ephrin B signaling                                                2.14E00    CDC42, GNB1, CFL2, RAC2, RHOA
  DNA double-strand break repair by nonhomologous end joining       2.13E00    XRCC1, XRCC4, PARP1
  Urate biosynthesis/inosine 5′- phosphate degradation              2.12E00    PRKDC, XRCC6, XRCC5, PARP1
  Telomere extension by Telomerase                                  2.11E00    HNRNPA1, HNRNPA2B1, XRCC5, XRCC6
  Rac signaling                                                     2.09E00    PAK2, CFL1, MAPK1, ARPC1B, RRAS, ITGA2, RAC1, IQGAP1, CDC42, CFL2, CD44, ARPC3, ARPC4, RHOA
  VEGF signaling                                                    2.08E00    ACTA1, ACTG1, ACTN1, ACTN4, EIF2S1, EIF2S2, EIF2S3, SFN, VCL, YWHAE
  Formaldehyde oxidation II (glutathione-dependent)                 2.05E00    ADH5, ESD
  p53 signaling                                                     2.03E00    PCNA, MAPK1
  Apoptosis signaling                                               1.77E00    ACIN1, CAPNS1, MAPK1, RRAS, LMNA, CAPN2, SPTAN1, CYCS, CDK1, PARP1, AIFM1
  Inosine-5′-phosphate biosynthesis II                              1.73E00    PAICS, ATIC
  Gap junction signaling                                            1.67E00    ACTA1, ACTG1, CAV1, EGFR, PDIA3, TUBA1B, TUBA1C, TUBA4A, TUBB, TUBB4B
  Antigen presentation pathway                                      1.64E00    CALR, CANX, HLA-A, PDIA3, PSMB5
  RAN signaling                                                     1.62E00    CSE1L, KPNA2, KPNB1, RAN
  eNOS signaling                                                    1.51E00    HSP90AA1, CAV1
  Pyruvate fermentation to lactate                                  1.45E00    LDHA, LDHB
  Breast cancer regulation by Stathmin1                             1.38E00    RHOA, PPP2R1A, TUBB6, RHOA, TUBA4A, PPP1CA
  ERK5 signaling                                                    1.35E00    EGFR, SFN, YWHAB, YWHAE, YWHAG, YWHAQ, YWHAZ
  tRNA charging                                                     1.26E00    AARS, GARS, RARS, TARS, WARS
  Arginine biosynthesis IV                                          1.26E00    OAT, GLUD1
  Mitotic roles of polo-like kinase                                 1.25E00    SLK, HSP90B1, PPP2R1A, HSP90AB1, PPP2CA, HSP90AA1, CAPN1
  Death receptor signaling                                          1.23E00    ACIN1, CYCS, ACTB, FADD
  Sucrose degradation V (Mammalian)                                 1.09E00    ALDOA, ALDOC, TPI1
  Cdc42 signaling                                                   1.08E00    ITGB1, ACTR2, PAK2, MYL6, ARPC1B, MAPK1, CFL1, HLA-A, ITGA2, IQGAP1, CDC42, ACTR3, CFL2, MYL12B, ARPC3, ARPC4
  Xanthine and xanthosine salvage                                   1.02E00    PNP
  Glutamate biosynthesis II                                         8.15E-01   GLUD1
  Mitochondrial dysfunction                                         7.5E-01    CYTB, VDAC2
  PTEN signaling                                                    7.32E-01   MAPK1, YWHAH, RRAS, CSNK2A1, RAC1, CSNK2B, CDC42
  Glutamate degradation X                                           7.01E-01   GLUD1
  Fatty acid biosynthesis initiation II                             6.5E-01    FASN
  Neuregulin signaling                                              6.39E-01   EGFR, RPS6, HSP90B1, MAPK1, HSP90AB1, RRAS, ITGA2, HSP90AA1
  Endoplasmic reticulum stress pathway                              5.98E-01   CALR, EIF2S1, HSP90B1, HSPA5
  Telomerase signaling                                              5.78E-01   EGFR, HSP90AA1, PPP2R1A
  CDK5 signaling                                                    5.46E-01   PPP2R1A, PPP1CA
  Role of tissue factor in cancer                                   5.15E-01   EGFR, AKT2, CFL2, MAPK1
  Isoleucine degradation I                                          5.06E-01   IMPDH2, PNP
  P70S6K signaling                                                  4.74E-01   EEF2, EGFR, PDIA3, PPP2R1A, SFN, YWHAB, YWHAE, YWHAG, YWHAQ, YWHAZ
  Axonal guidance signaling                                         4.51E-01   DPYSL2, RAC2, AKT2, MYL6, PDIA3, TUBA4A, ACTR3, TUBB6, CFL2, RHOA, RTN4, ARPC3, PFN2, PFN1, PSMD14
  Role of PKR in interferon induction and antiviral response        4.16E-01   CYCS
  Protein kinase A signaling                                        3.54E-01   APEX1, FLNA, FLNB, GNB2L1, HSF3A/H3F3B, MYL12A, PDE6H, PDIA3, PPP1CA, PYGB, PYGL, RHOA, SFN, YWHAB, YWHAE, YWHAG, YWHAQ, YWHAZ
  Macropinocytosis signaling                                        3.53E-01   RHOA, ITGB1, RRAS, RAC1, ACTN4
  HIPPO signaling                                                   3.27E-01   PPP1CA, PPP2R1A, SFN, YWHAB, YWHAE, YWHAG, YWHAQ, YWHAZ
  Nitric oxide signaling in the cardiovascular system               2.86E-01   CAV1, HSP90AB1
  Glucocorticoid receptor signaling                                 2.82E-01   HMGB1, AKT2, HSP90AA1, STAT1
  Fcy receptor-mediated phagocytosis in macrophages and monocytes   2.5E-01    RAC, CDC42
  Tec kinase signaling                                              2.49E-01   RHO, STAT, FADD
  Activation of IRF by cytosolic pattern recognition receptors      2.45E-01   PPIB, MAVS, ADAR, ISG15, STAT2, CYPB
  Prostate cancer signaling                                         2.22E-01   HSP90B1, MAPK1, PA2G4, HSP90AB1, RRAS, HSP90AA1, CTNNB1, GSTP1
  HGF signaling                                                     1.78E-01   AKT2

**Abbreviations:** ACT, actin; ACTN, actinin; ACTR3, ACTR3 actin-related 3 homolog; Akt, protein kinase B; ALDH, aldehyde dehydrogenase; ARPC, actin related protein 2/3 complex; CAV1, caveolin 1; CDC, cell division cycle; CDK, cyclin-dependent kinase; COPA, coatomer protein complex subunit alpha; CTNN, cadherin-associated protein; DNM1L, dynamin 1-like; EGFR, epidermal growth factor receptor; EIF, eukaryotic initiation factor; eNOS, endothelial nitric oxide synthase; FADD, Fas (TNFRSF6)-associated via death domain; FLN, filamin; GSTP1, glutathione S-transferase pi 1; HLA-A, major histocompatibility complex class I; HGF, hepatocyte growth factor; HMGB1, high mobility group protein B1; HSP, heat shock protein; IQGAP1, IQ motif containing GTPase activating protein 1; ITGB, intergrin beta; NQO1, NAD(P)H: quinone oxidoreductase 1; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; Nrf2, Nuclear factor erythroid 2-related factor 2; PA2G4, proliferation-associated 2G4; PAK, p21-activated kinase; PABPC1, poly(A) binding protein cytoplasmic 1; PI3K, phosphoinositide 3-kinase; PLB, plumbagin; PPIB, peptidylprolyl isomerase B; PSM, proteasome subunit; PTEN, phosphatase and tensin-like protein; RAR, retinoic acid receptor; RHO, Ras homolog gene family; RhoGDI, Rho GDP-dissociation inhibitor; RPS, ribosomal protein S; RPL, ribosomal protein L; S6K, S6 kinase; SOD, superoxide dismutase; STAT, signal transducer and activator of transcription; TUBA, tubulin alpha; VEGF, vascular endothelial growth factor; VIM, vimentin.
